☰

James M. Gold - Publications

Affiliations: 
University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
Neuropsychology, Schizophrenia
Tree Info Grants Similar researchers PubMed Report error

411 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Culbreth AJ, Moran EK, Mahaphanit W, Erickson MA, Boudewyn MA, Frank MJ, Barch DM, MacDonald AW, Daniel Ragland J, Luck SJ, Silverstein SM, Carter CS, Gold JM. A Transdiagnostic Study of Effort-Cost Decision-Making in Psychotic and Mood Disorders. Schizophrenia Bulletin. PMID 37901911 DOI: 10.1093/schbul/sbad155  0.628
2023 Pratt DN, Luther L, Kinney KS, Osborne KJ, Corlett PR, Powers AR, Woods SW, Gold JM, Schiffman J, Ellman LM, Strauss GP, Walker EF, Zinbarg R, Waltz JA, Silverstein SM, et al. Comparing a Computerized Digit Symbol Test to a Pen-and-Paper Classic. Schizophrenia Bulletin Open. 4: sgad027. PMID 37868160 DOI: 10.1093/schizbullopen/sgad027  0.612
2023 Bansal S, Bae GY, Robinson BM, Dutterer J, Hahn B, Luck SJ, Gold JM. Qualitatively different delay-dependent working memory distortions in people with schizophrenia and healthy control subjects. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 37459911 DOI: 10.1016/j.bpsc.2023.07.004  0.629
2023 Dalloul N, Moran EK, Gold JM, Carter CS, MacDonald AW, Ragland JD, Silverstein SM, Luck SJ, Barch DM. Transdiagnostic Predictors of Everyday Functioning: Examining the Relationships of Depression and Reinforcement Learning. Schizophrenia Bulletin. PMID 37382553 DOI: 10.1093/schbul/sbad095  0.493
2023 Gold JM, Corlett PR, Erickson M, Waltz JA, August S, Dutterer J, Bansal S. Phenomenological and Cognitive Features Associated With Auditory Hallucinations in Clinical and Nonclinical Voice Hearers. Schizophrenia Bulletin. PMID 37350507 DOI: 10.1093/schbul/sbad083  0.808
2023 Dutterer J, Bansal S, Robinson B, Gold JM. Sustained attention deficits in schizophrenia: Effect of memory load on the Identical Pairs Continuous Performance Test. Schizophrenia Research. Cognition. 33: 100288. PMID 37273835 DOI: 10.1016/j.scog.2023.100288  0.639
2023 Bansal S, Bae GY, Robinson BM, Dutterer J, Hahn B, Luck SJ, Gold JM. Qualitatively different delay-dependent working memory distortions in people with schizophrenia and healthy control subjects. Biorxiv : the Preprint Server For Biology. PMID 37066149 DOI: 10.1101/2023.04.04.535597  0.628
2023 Karp EL, Williams TF, Ellman LM, Strauss GP, Walker EF, Corlett PR, Woods SW, Powers AR, Gold JM, Schiffman JE, Waltz JA, Silverstein SM, Mittal VA. Self-reported Gesture Interpretation and Performance Deficits in Individuals at Clinical High Risk for Psychosis. Schizophrenia Bulletin. PMID 36939086 DOI: 10.1093/schbul/sbac197  0.64
2023 Williams TF, Walker EF, Strauss GP, Woods SW, Powers AR, Corlett PR, Schiffman J, Waltz JA, Gold JM, Silverstein SM, Ellman LM, Zinbarg RE, Mittal VA. The reliability and validity of the Revised Green et al. Paranoid Thoughts Scale in individuals at clinical high-risk for psychosis. Acta Psychiatrica Scandinavica. PMID 36905387 DOI: 10.1111/acps.13545  0.581
2023 Corlett PR, Bansal S, Gold JM. Studying Healthy Psychosislike Experiences to Improve Illness Prediction. Jama Psychiatry. PMID 36884241 DOI: 10.1001/jamapsychiatry.2023.0059  0.431
2023 Calarco N, Oliver LD, Joseph M, Hawco C, Dickie EW, DeRosse P, Gold JM, Foussias G, Argyelan M, Malhotra AK, Buchanan RW, Voineskos AN. Multivariate Associations Among White Matter, Neurocognition, and Social Cognition Across Individuals With Schizophrenia Spectrum Disorders and Healthy Controls. Schizophrenia Bulletin. PMID 36869812 DOI: 10.1093/schbul/sbac216  0.364
2023 Culbreth AJ, Schwartz EK, Frank MJ, Brown EC, Xu Z, Chen S, Gold JM, Waltz JA. A computational neuroimaging study of reinforcement learning and goal-directed exploration in schizophrenia spectrum disorders. Psychological Medicine. 1-11. PMID 36752156 DOI: 10.1017/S0033291722003993  0.429
2022 Kwashie AN, Ma Y, Barch DM, Chafee M, Ragland JD, Silverstein SM, Carter CS, Gold JM, MacDonald AW. Comparing the functional neuroanatomy of proactive and reactive control between patients with schizophrenia and healthy controls. Cognitive, Affective & Behavioral Neuroscience. PMID 36418846 DOI: 10.3758/s13415-022-01036-6  0.594
2022 Erickson MA, Lopez-Calderon J, Robinson B, Gold JM, Luck SJ. Gamma-band entrainment abnormalities in schizophrenia: Modality-specific or cortex-wide impairment? Journal of Psychopathology and Clinical Science. 131: 895-905. PMID 36326630 DOI: 10.1037/abn0000778  0.584
2022 Barch DM, Boudewyn MA, Carter CC, Erickson M, Frank MJ, Gold JM, Luck SJ, MacDonald AW, Ragland JD, Ranganath C, Silverstein SM, Yonelinas A. Cognitive [Computational] Neuroscience Test Reliability and Clinical Applications for Serious Mental Illness (CNTRaCS) Consortium: Progress and Future Directions. Current Topics in Behavioral Neurosciences. PMID 36173600 DOI: 10.1007/7854_2022_391  0.7
2022 Gold JM, Luck SJ. Working Memory in People with Schizophrenia. Current Topics in Behavioral Neurosciences. PMID 35915383 DOI: 10.1007/7854_2022_381  0.463
2022 Luck SJ, Gold JM. Attention in Schizophrenia. Current Topics in Behavioral Neurosciences. PMID 35902544 DOI: 10.1007/7854_2022_380  0.447
2022 Millman ZB, Schiffman J, Gold JM, Akouri-Shan L, Demro C, Fitzgerald J, Rakhshan Rouhakhtar PJ, Klaunig M, Rowland LM, Waltz JA. Linking Salience Signaling With Early Adversity and Affective Distress in Individuals at Clinical High Risk for Psychosis: Results From an Event-Related fMRI Study. Schizophrenia Bulletin Open. 3: sgac039. PMID 35799887 DOI: 10.1093/schizbullopen/sgac039  0.585
2022 Catalano LT, Wynn JK, Green MF, Gold JM. Reduced neural activity when anticipating social versus nonsocial rewards in schizophrenia: Preliminary evidence from an ERP study. Schizophrenia Research. 246: 7-16. PMID 35696860 DOI: 10.1016/j.schres.2022.05.028  0.342
2022 Williams TF, Powers AR, Ellman LM, Corlett PR, Strauss GP, Schiffman J, Waltz JA, Silverstein SM, Woods SW, Walker EF, Gold JM, Mittal VA. Three prominent self-report risk measures show unique and overlapping utility in characterizing those at clinical high-risk for psychosis. Schizophrenia Research. 244: 58-65. PMID 35597134 DOI: 10.1016/j.schres.2022.05.006  0.59
2022 Spilka MJ, Keller WR, Buchanan RW, Gold JM, Koenig JI, Strauss GP. Endogenous oxytocin levels are associated with facial emotion recognition accuracy but not gaze behavior in individuals with schizophrenia. Acta Psychiatrica Scandinavica. PMID 35243618 DOI: 10.1111/acps.13421  0.338
2021 Culbreth AJ, Kasanova Z, Ross TJ, Salmeron BJ, Gold JM, Stein EA, Waltz JA. Schizophrenia Patients Show Largely Similar Salience Signaling Compared to Healthy Controls in an Observational Task Environment. Brain Sciences. 11. PMID 34942913 DOI: 10.3390/brainsci11121610  0.65
2021 Bansal S, Bae GY, Robinson BM, Hahn B, Waltz J, Erickson M, Leptourgos P, Corlett P, Luck SJ, Gold JM. Association Between Failures in Perceptual Updating and the Severity of Psychosis in Schizophrenia. Jama Psychiatry. PMID 34851373 DOI: 10.1001/jamapsychiatry.2021.3482  0.798
2021 Bansal S, Gaspelin N, Robinson BM, Hahn B, Luck SJ, Gold JM. Oculomotor inhibition and location priming in schizophrenia. Journal of Abnormal Psychology. 130: 651-664. PMID 34553960 DOI: 10.1037/abn0000683  0.606
2021 Hahn B, Robinson BM, Kiat JE, Geng J, Bansal S, Luck SJ, Gold JM. Impaired Filtering and Hyperfocusing: Neural Evidence for Distinct Selective Attention Abnormalities in People with Schizophrenia. Cerebral Cortex (New York, N.Y. : 1991). PMID 34546344 DOI: 10.1093/cercor/bhab327  0.6
2021 Erickson MA, Hahn B, Kiat JE, Alliende LM, Luck SJ, Gold JM. Neural basis of the visual working memory deficit in schizophrenia: Merging evidence from fMRI and EEG. Schizophrenia Research. 236: 61-68. PMID 34399233 DOI: 10.1016/j.schres.2021.07.039  0.596
2021 Mittal VA, Ellman LM, Strauss GP, Walker EF, Corlett PR, Schiffman J, Woods SW, Powers AR, Silverstein SM, Waltz JA, Zinbarg R, Chen S, Williams T, Kenney J, Gold JM. Computerized Assessment of Psychosis Risk. Journal of Psychiatry and Brain Science. 6. PMID 34307899 DOI: 10.20900/jpbs.20210011  0.597
2021 Akouri-Shan L, Schiffman J, Millman ZB, Demro C, Fitzgerald J, Rakhshan Rouhakhtar PJ, Redman S, Reeves GM, Chen S, Gold JM, Martin EA, Corcoran C, Roiser JP, Buchanan RW, Rowland LM, et al. Relations Among Anhedonia, Reinforcement Learning, and Global Functioning in Help-seeking Youth. Schizophrenia Bulletin. PMID 34240217 DOI: 10.1093/schbul/sbab075  0.653
2021 Silverstein SM, Thompson JL, Gold JM, Schiffman J, Waltz JA, Williams TF, Zinbarg RE, Mittal VA, Ellman LM, Strauss GP, Walker EF, Woods SW, Levin JA, Kafadar E, Kenney J, et al. Increased face detection responses on the mooney faces test in people at clinical high risk for psychosis. Npj Schizophrenia. 7: 26. PMID 34001909 DOI: 10.1038/s41537-021-00156-1  0.623
2021 Pratt DN, Barch DM, Carter CS, Gold JM, Ragland JD, Silverstein SM, MacDonald AW. Reliability and Replicability of Implicit and Explicit Reinforcement Learning Paradigms in People With Psychotic Disorders. Schizophrenia Bulletin. 47: 731-739. PMID 33914891 DOI: 10.1093/schbul/sbaa165  0.52
2021 Geana A, Barch DM, Gold JM, Carter CS, MacDonald AW, Ragland JD, Silverstein SM, Frank MF. Using Computational Modelling to Capture Schizophrenia-Specific Reinforcement Learning Differences and Their Implications on Patient Classification. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 33878489 DOI: 10.1016/j.bpsc.2021.03.017  0.623
2021 Nassar MR, Waltz JA, Albrecht MA, Gold JM, Frank MJ. All or nothing belief updating in patients with schizophrenia reduces precision and flexibility of beliefs. Brain : a Journal of Neurology. PMID 33434284 DOI: 10.1093/brain/awaa453  0.683
2020 Waltz JA, Wilson RC, Albrecht MA, Frank MJ, Gold JM. Differential Effects of Psychotic Illness on Directed and Random Exploration. Computational Psychiatry (Cambridge, Mass.). 4: 18-39. PMID 33768158 DOI: 10.1162/cpsy_a_00027  0.677
2020 Culbreth AJ, Wu Q, Chen S, Adhikari BM, Hong LE, Gold JM, Waltz JA. Temporal-thalamic and cingulo-opercular connectivity in people with schizophrenia. Neuroimage. Clinical. 29: 102531. PMID 33340977 DOI: 10.1016/j.nicl.2020.102531  0.606
2020 Beaudette DM, Gold JM, Waltz J, Thompson JL, Cherneski L, Martin V, Monteiro B, Cruz LN, Silverstein SM. Predicting Attention-Shaping Response in People With Schizophrenia. The Journal of Nervous and Mental Disease. PMID 33315800 DOI: 10.1097/NMD.0000000000001286  0.67
2020 Bansal S, Bae GY, Frankovich K, Robinson BM, Leonard CJ, Gold JM, Luck SJ. Increased repulsion of working memory representations in schizophrenia. Journal of Abnormal Psychology. PMID 32881536 DOI: 10.1037/Abn0000637  0.799
2020 Dwyer KR, Andrea AM, Savage CLG, Orth RD, Shan L, Strauss GP, Adams HA, Kelly DL, Weiner E, Gold JM, McMahon RP, Carpenter WT, Buchanan RW, Blanchard JJ. A Randomized Clinical Trial of Oxytocin or Galantamine in Schizophrenia: Assessing the Impact on Behavioral, Lexical, and Self-Report Indicators of Social Affiliation. Schizophrenia Bulletin Open. 1: sgaa001. PMID 32803156 DOI: 10.1093/schizbullopen/sgaa001  0.339
2020 Moran EK, Gold JM, Carter CS, MacDonald AW, Ragland JD, Silverstein SM, Luck SJ, Barch DM. Both unmedicated and medicated individuals with schizophrenia show impairments across a wide array of cognitive and reinforcement learning tasks. Psychological Medicine. 1-11. PMID 32799938 DOI: 10.1017/S003329172000286X  0.66
2020 Buchanan RW, Weiner E, Kelly DL, Gold JM, Chen S, Zaranski J, Blatt F, Wehring H, Carpenter WT. Anti-inflammatory Combination Therapy for the Treatment of Schizophrenia. Journal of Clinical Psychopharmacology. PMID 32796391 DOI: 10.1097/Jcp.0000000000001253  0.465
2020 Bansal S, Gaspar JM, Robinson BM, Leonard CJ, Hahn B, Luck SJ, Gold JM. Antisaccade Deficits in Schizophrenia Can Be Driven by Attentional Relevance of the Stimuli. Schizophrenia Bulletin. PMID 32766726 DOI: 10.1093/Schbul/Sbaa106  0.791
2020 Gold JM, Bansal S, Anticevic A, Cho YT, Repovš G, Murray JD, Hahn B, Robinson BM, Luck SJ. Refining the Empirical Constraints on Computational Models of Spatial Working Memory in Schizophrenia. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 32741701 DOI: 10.1016/J.Bpsc.2020.05.003  0.677
2020 Culbreth AJ, Waltz JA, Frank MJ, Gold JM. Retention of Value Representations Across Time in People With Schizophrenia and Healthy Control Subjects. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 32712211 DOI: 10.1016/J.Bpsc.2020.05.009  0.728
2020 Gold JM, Corlett PR, Strauss GP, Schiffman J, Ellman LM, Walker EF, Powers AR, Woods SW, Waltz JA, Silverstein SM, Mittal VA. Enhancing Psychosis Risk Prediction Through Computational Cognitive Neuroscience. Schizophrenia Bulletin. PMID 32648913 DOI: 10.1093/Schbul/Sbaa091  0.677
2020 Kafadar E, Mittal VA, Strauss GP, Chapman HC, Ellman LM, Bansal S, Gold JM, Alderson-Day B, Evans S, Moffatt J, Silverstein SM, Walker EF, Woods SW, Corlett PR, Powers AR. Modeling perception and behavior in individuals at clinical high risk for psychosis: Support for the predictive processing framework. Schizophrenia Research. PMID 32593735 DOI: 10.1016/J.Schres.2020.04.017  0.559
2020 Dickerson F, Schroeder JR, Nimgaonkar V, Gold J, Yolken R. The association between exposure to herpes simplex virus type 1 (HSV-1) and cognitive functioning in schizophrenia: A meta-analysis. Psychiatry Research. 291: 113157. PMID 32593064 DOI: 10.1016/J.Psychres.2020.113157  0.5
2020 Cowan HR, Mittal VA, Allen DN, Gold JM, Strauss GP. Heterogeneity of emotional experience in schizophrenia: Trait affect profiles predict clinical presentation and functional outcome. Journal of Abnormal Psychology. PMID 32584084 DOI: 10.1037/Abn0000554  0.429
2020 Hahn B, Bae GY, Robinson BM, Leonard CJ, Luck SJ, Gold JM. Cortical hyperactivation at low working memory load: A primary processing abnormality in people with schizophrenia? Neuroimage. Clinical. 26: 102270. PMID 32388334 DOI: 10.1016/J.Nicl.2020.102270  0.748
2020 Leonard CJ, Robinson BM, Hahn B, Gold JM, Luck SJ. Increased influence of a previously attended feature in people with schizophrenia. Journal of Abnormal Psychology. 129: 305-311. PMID 32212750 DOI: 10.1037/Abn0000511  0.774
2020 Bae GY, Leonard CJ, Hahn B, Gold JM, Luck SJ. Assessing the information content of ERP signals in schizophrenia using multivariate decoding methods. Neuroimage. Clinical. 25: 102179. PMID 31954988 DOI: 10.1016/J.Nicl.2020.102179  0.707
2020 Kraus MS, Gold JM, Barch DM, Walker TM, Chun CA, Buchanan RW, Csernansky JG, Goff DC, Green MF, Jarskog LF, Javitt DC, Kimhy D, Lieberman JA, McEvoy JP, Mesholam-Gately RI, et al. The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measures. Schizophrenia Research. Cognition. 19: 100161. PMID 31832342 DOI: 10.1016/J.Scog.2019.100161  0.44
2020 Waltz JA, Wilson RC, Albrecht MA, Frank MJ, Gold JM. Differential Effects of Psychotic Illness on Directed and Random Exploration Computational Psychiatry. 4: 18-39. DOI: 10.1162/cpsy_a_00027  0.677
2020 Ponomareva OY, Redman B, Sayer MA, Wehring HJ, Vyas G, Richardson CM, Gold JM, Gorelick DA, Cihakova D, Talor MV, Hoag SW, Buchanan RW, Wang J, Chen S, Liu F, et al. L-Tetrahydropalmatine, a Novel Dopamine Antagonist, Fails to Improve Psychiatric Symptoms as Adjunctive Treatment for Schizophrenia Schizophrenia Bulletin Open. 1. DOI: 10.1093/SCHIZBULLOPEN/SGAA026  0.336
2020 Kwashie A, Ma Y, Poppe A, Barch D, Carter C, Chaffee M, Gold J, Ragland JD, Silverstein S, MacDonald A. S140. CHARACTERISTICS OF COGNITIVE CONTROL SPECIALIZATION IN HEALTHY AND PATIENT POPULATIONS Schizophrenia Bulletin. 46: S89-S89. DOI: 10.1093/Schbul/Sbaa031.206  0.601
2020 Waltz J, Hernaus D, Wilson R, Brown E, Frank M, Gold J. T62. A COMPUTATIONAL ANALYSIS OF MOTIVATIONAL DEFICITS IN SCHIZOPHRENIA SPECTRUM DISORDERS Schizophrenia Bulletin. 46: S255-S255. DOI: 10.1093/Schbul/Sbaa029.622  0.723
2020 Cowan H, Mittal V, Allen D, Gold J, Strauss G. O3.1. CLUSTER ANALYSIS FINDS THREE CLINICALLY-RELEVANT SUBGROUPS OF TRAIT EMOTIONAL EXPERIENCE IN SCHIZOPHRENIA OUTPATIENTS Schizophrenia Bulletin. 46: S5-S6. DOI: 10.1093/Schbul/Sbaa028.012  0.43
2020 Bansal S, Erickson M, Waltz J, Corlett P, Gold J. Altered Attribution of Temporal Causality During Intentional Action is Differentially Associated With Grandiosity and Passivity Type Delusions Biological Psychiatry. 87: S360-S361. DOI: 10.1016/J.Biopsych.2020.02.924  0.729
2020 Culbreth A, Waltz J, Frank M, Gold J. Negative Symptoms in People With Schizophrenia are Associated With Reduced Long-Term Retention of Reward Information Biological Psychiatry. 87: S310-S311. DOI: 10.1016/J.Biopsych.2020.02.800  0.708
2020 Tang S, Hänsel K, DeRosse P, Oliver L, Khairullah A, Gold J, Buchanan R, Voineskos A, Malhotra A. Metabolic Disturbances are Associated With Impaired Social Cognition in Schizophrenia Spectrum Disorders Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.790  0.463
2020 Gold J, Bansal S, Erickson M, Waltz J, Corlett P. Overweighting of Initial Motion Information Correlates With Severity of Positive Symptoms in Schizophrenia Biological Psychiatry. 87: S207-S208. DOI: 10.1016/J.Biopsych.2020.02.539  0.794
2020 Hahn B, Robinson B, Luck S, Gold J. Neural Mechanisms of Selective Attention Deficits in People With Schizophrenia Biological Psychiatry. 87: S203-S204. DOI: 10.1016/J.Biopsych.2020.02.529  0.522
2019 Ray KL, Ragland JD, MacDonald AW, Gold JM, Silverstein SM, Barch DM, Carter CS. Dynamic reorganization of the frontal parietal network during cognitive control and episodic memory. Cognitive, Affective & Behavioral Neuroscience. PMID 31811557 DOI: 10.3758/S13415-019-00753-9  0.566
2019 Damme KSF, Osborne KJ, Gold JM, Mittal VA. Detecting motor slowing in clinical high risk for psychosis in a computerized finger tapping model. European Archives of Psychiatry and Clinical Neuroscience. PMID 31432263 DOI: 10.1007/S00406-019-01059-0  0.363
2019 Luck SJ, Hahn B, Leonard CJ, Gold JM. The Hyperfocusing Hypothesis: A New Account of Cognitive Dysfunction in Schizophrenia. Schizophrenia Bulletin. PMID 31317191 DOI: 10.1093/Schbul/Sbz063  0.787
2019 Luck SJ, Leonard CJ, Hahn B, Gold JM. Is Attentional Filtering Impaired in Schizophrenia? Schizophrenia Bulletin. PMID 31206163 DOI: 10.1093/Schbul/Sbz045  0.738
2019 Bansal S, Robinson BM, Leonard CJ, Hahn B, Luck SJ, Gold JM. Failures in top-down control in schizophrenia revealed by patterns of saccadic eye movements. Journal of Abnormal Psychology. PMID 31192637 DOI: 10.1037/Abn0000442  0.75
2019 Gold JM, Bansal S, Gaspar JM, Chen S, Robinson BM, Hahn B, Luck SJ. People with schizophrenia show enhanced cognitive costs of maintaining a single item in working memory. Psychological Medicine. 1-7. PMID 31088582 DOI: 10.1017/S0033291719000862  0.665
2019 Millman ZB, Gallagher K, Demro C, Schiffman J, Reeves GM, Gold JM, Rakhshan Rouhakhtar PJ, Fitzgerald J, Andorko ND, Redman S, Buchanan RW, Rowland LM, Waltz JA. Evidence of reward system dysfunction in youth at clinical high-risk for psychosis from two event-related fMRI paradigms. Schizophrenia Research. PMID 30995969 DOI: 10.1016/J.Schres.2019.03.017  0.665
2019 Smucny J, Iosif AM, Eaton NR, Lesh TA, Ragland JD, Barch DM, Gold JM, Strauss ME, MacDonald AW, Silverstein SM, Carter CS. Latent Profiles of Cognitive Control, Episodic Memory, and Visual Perception Across Psychiatric Disorders Reveal a Dimensional Structure. Schizophrenia Bulletin. PMID 30953588 DOI: 10.1093/Schbul/Sbz025  0.61
2019 Kelly DL, Demyanovich HK, Rodriguez KM, Ciháková D, Talor MV, McMahon RP, Richardson CM, Vyas G, Adams HA, August SM, Fasano A, Cascella NG, Feldman SM, Liu F, Sayer MA, ... ... Gold JM, et al. Randomized controlled trial of a gluten-free diet in patients with schizophrenia positive for antigliadin antibodies (AGA IgG): a pilot feasibility study Journal of Psychiatry & Neuroscience : Jpn. 44: 1-9. PMID 30938127 DOI: 10.1503/Jpn.180174  0.456
2019 Strauss GP, Chapman HC, Keller WR, Koenig JI, Gold JM, Carpenter WT, Buchanan RW. Endogenous oxytocin levels are associated with impaired social cognition and neurocognition in schizophrenia. Journal of Psychiatric Research. 112: 38-43. PMID 30849617 DOI: 10.1016/J.Jpsychires.2019.02.017  0.418
2019 Smucny J, Barch DM, Gold JM, Strauss ME, MacDonald AW, Boudewyn MA, Ragland JD, Silverstein SM, Carter CS. Cross-diagnostic analysis of cognitive control in mental illness: Insights from the CNTRACS consortium. Schizophrenia Research. PMID 30704863 DOI: 10.1016/J.Schres.2019.01.018  0.613
2019 Strauss GP, Esfahlani FZ, Kirkpatrick B, Allen DN, Gold JM, Visser KF, Sayama H. Network Analysis Reveals Which Negative Symptom Domains Are Most Central in Schizophrenia vs Bipolar Disorder. Schizophrenia Bulletin. PMID 30649527 DOI: 10.1093/Schbul/Sby168  0.373
2019 Millman ZB, Gold JM, Mittal VA, Schiffman J. The Critical Need for Help-Seeking Controls in Clinical High-Risk Research Clinical Psychological Science. 7: 1171-1189. DOI: 10.1177/2167702619855660  0.309
2019 Gold J, Bansal S, Hahn B, Robinson B, Luck S. O4.3. PEOPLE WITH SCHIZOPHRENIA SHOW GREATER COGNITIVE COSTS OF STORING A SINGLE ITEM IN WORKING MEMORY Schizophrenia Bulletin. 45: S169-S170. DOI: 10.1093/Schbul/Sbz021.203  0.635
2019 Waltz J, Hernaus D, Nassar M, Ritz H, Xu Z, Frank M, Ruiz R, Gold J. S45. DEFICITS IN INFORMATION-SEEKING BEHAVIOR IN SCHIZOPHRENIA: AN ALTERNATIVE MECHANISM OF AVOLITION Schizophrenia Bulletin. 45: S323-S323. DOI: 10.1093/Schbul/Sbz020.590  0.714
2019 Bansal S, Bae G, Robinson BR, Luck SJ, Gold J. S41. INFLUENCE OF PRIORS ON MOTION PERCEPTION IN SCHIZOPHRENIA Schizophrenia Bulletin. 45: S321-S322. DOI: 10.1093/Schbul/Sbz020.586  0.615
2019 Chang WC, Wo SF, Wong CF, Lee HC, Waltz J, Gold J, Chan SI, Chiu S, Lee HM, Chan KW, Hui LM, Suen YN, Chen E. T47. REINFORCEMENT LEARNING IMPAIRMENT AND PRIMARY NEGATIVE SYMPTOMS IN INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS Schizophrenia Bulletin. 45: S222-S222. DOI: 10.1093/Schbul/Sbz019.327  0.64
2019 Hernaus D, Xu Z, Ruiz R, Brown E, Nassar M, Ritz H, Gold J, Frank M, Waltz J. F9. REDUCED UNCERTAINTY-DRIVEN EXPLORATION AND ASSOCIATED NEURAL REWARD-RELATED SIGNALS RELATE TO MOTIVATIONAL DEFICIT SEVERITY Schizophrenia Bulletin. 45: S257-S258. DOI: 10.1093/Schbul/Sbz018.421  0.76
2019 Hernaus D, Gold J, Waltz J, Frank M. Converging evidence linking reinforcement learning deficits in schizophrenia to impairments in the representation of expected value European Neuropsychopharmacology. 29: S402-S403. DOI: 10.1016/J.Euroneuro.2018.11.609  0.737
2019 Hahn B, Erickson M, Robinson B, Leonard C, Luck S, Gold J. 17. Blunted Tuning of Posterior Parietal Cortex Activity is Central to Working Memory Storage Deficits in Schizophrenia Biological Psychiatry. 85: S7. DOI: 10.1016/J.Biopsych.2019.03.031  0.789
2018 Hernaus D, Frank MJ, Brown EC, Brown JK, Gold JM, Waltz JA. Impaired Expected Value Computations in Schizophrenia Are Associated With a Reduced Ability to Integrate Reward Probability and Magnitude of Recent Outcomes. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 30683607 DOI: 10.1016/J.Bpsc.2018.11.011  0.841
2018 Hernaus D, Xu Z, Brown EC, Ruiz R, Frank MJ, Gold JM, Waltz JA. Motivational deficits in schizophrenia relate to abnormalities in cortical learning rate signals. Cognitive, Affective & Behavioral Neuroscience. PMID 30276616 DOI: 10.3758/S13415-018-0643-Z  0.799
2018 Gold JM, Barch DM, Feuerstahler LM, Carter CS, MacDonald AW, Ragland JD, Silverstein SM, Strauss ME, Luck SJ. Working Memory Impairment Across Psychotic disorders. Schizophrenia Bulletin. PMID 30260448 DOI: 10.1093/Schbul/Sby134  0.576
2018 Strauss GP, Nuñez A, Ahmed AO, Barchard KA, Granholm E, Kirkpatrick B, Gold JM, Allen DN. The Latent Structure of Negative Symptoms in Schizophrenia. Jama Psychiatry. PMID 30208377 DOI: 10.1001/Jamapsychiatry.2018.2475  0.358
2018 Strauss GP, Granholm E, Holden JL, Ruiz I, Gold JM, Kelly DL, Buchanan RW. The effects of combined oxytocin and cognitive behavioral social skills training on social cognition in schizophrenia. Psychological Medicine. 1-9. PMID 30180918 DOI: 10.1017/S0033291718002465  0.442
2018 Oliver LD, Haltigan JD, Gold JM, Foussias G, DeRosse P, Buchanan RW, Malhotra AK, Voineskos AN. Lower- and Higher-Level Social Cognitive Factors Across Individuals With Schizophrenia Spectrum Disorders and Healthy Controls: Relationship With Neurocognition and Functional Outcome. Schizophrenia Bulletin. PMID 30107517 DOI: 10.1093/Schbul/Sby114  0.468
2018 Hahn B, Robinson BM, Leonard CJ, Luck SJ, Gold JM. Posterior Parietal Cortex Dysfunction is Central to Working Memory Storage and Broad Cognitive Deficits in Schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30104335 DOI: 10.1523/Jneurosci.0913-18.2018  0.779
2018 Catalano LT, Heerey EA, Gold JM. The valuation of social rewards in schizophrenia. Journal of Abnormal Psychology. 127: 602-611. PMID 30102066 DOI: 10.1037/Abn0000366  0.45
2018 Bansal S, Robinson BM, Geng JJ, Leonard CJ, Hahn B, Luck SJ, Gold JM. The impact of reward on attention in schizophrenia. Schizophrenia Research. Cognition. 12: 66-73. PMID 29928599 DOI: 10.1016/J.Scog.2018.05.001  0.772
2018 Ahmed AO, Kirkpatrick B, Galderisi S, Mucci A, Rossi A, Bertolino A, Rocca P, Maj M, Kaiser S, Bischof M, Hartmann-Riemer MN, Kirschner M, Schneider K, Garcia-Portilla MP, Mane A, ... ... Gold JM, et al. Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in Schizophrenia. Schizophrenia Bulletin. PMID 29912473 DOI: 10.1093/Schbul/Sby050  0.347
2018 Viviano JD, Buchanan RW, Calarco N, Gold JM, Foussias G, Bhagwat N, Stefanik L, Hawco C, DeRosse P, Argyelan M, Turner J, Chavez S, Kochunov P, Kingsley P, Zhou X, et al. Resting-State Connectivity Biomarkers of Cognitive Performance and Social Function in Individuals With Schizophrenia Spectrum Disorder and Healthy Control Subjects. Biological Psychiatry. PMID 29779671 DOI: 10.1016/J.Biopsych.2018.03.013  0.487
2018 Hernaus D, Gold JM, Waltz JA, Frank MJ. Impaired Expected Value Computations Coupled With Overreliance on Stimulus-Response Learning in Schizophrenia. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 29735404 DOI: 10.1016/J.Bpsc.2018.03.014  0.734
2018 Albrecht MA, Waltz JA, Cavanagh JF, Frank MJ, Gold JM. Increased conflict-induced slowing, but no differences in conflict-induced positive or negative prediction error learning in patients with schizophrenia. Neuropsychologia. PMID 29709580 DOI: 10.1016/J.Neuropsychologia.2018.04.031  0.717
2018 Wehring HJ, Buchanan RW, Feldman S, Carpenter WT, McMahon RP, Weiner E, Gold JM, Adams HA, Strauss GP, Rubin LH, Kelly DL. Oxytocin and sexual function in males and females with schizophrenia. Schizophrenia Research. PMID 29551232 DOI: 10.1016/J.Schres.2018.03.013  0.383
2018 Strauss GP, Visser KF, Keller WR, Gold JM, Buchanan RW. Anhedonia reflects impairment in making relative value judgments between positive and neutral stimuli in schizophrenia. Schizophrenia Research. PMID 29499966 DOI: 10.1016/J.Schres.2018.02.016  0.431
2018 Waltz JA, Xu Z, Brown EC, Ruiz RR, Frank MJ, Gold JM. Motivational Deficits in Schizophrenia Are Associated With Reduced Differentiation Between Gain and Loss-Avoidance Feedback in the Striatum. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 3: 239-247. PMID 29486865 DOI: 10.1016/J.Bpsc.2017.07.008  0.833
2018 Oliver L, Haltigan J, Gold J, Foussias G, DeRosse P, Buchanan R, Malhotra A, Voineskos A. S245. LOWER- AND HIGHER-LEVEL SOCIAL COGNITIVE FACTORS ACROSS INDIVIDUALS WITH SCHIZOPHRENIA SPECTRUM DISORDERS AND HEALTHY CONTROLS: RELATIONSHIP WITH NEUROCOGNITION AND FUNCTIONAL OUTCOME Schizophrenia Bulletin. 44: S422-S422. DOI: 10.1093/schbul/sby018.1032  0.355
2018 Kelly D, Demyanovich H, Rodriguez K, Cihakova D, Talor M, Gold J, August S, Buchanan R, Feldman S, Liu F, Carpenter W, Eaton W. T191. RANDOMIZED DOUBLE-BLIND FEASIBILITY STUDY OF A GLUTEN-FREE DIET IN PEOPLE WITH SCHIZOPHRENIA AND ELEVATED ANTIGLIADIN ANTIBODIES (AGA IGG) Schizophrenia Bulletin. 44: S190-S190. DOI: 10.1093/Schbul/Sby016.467  0.401
2018 Czepielewski L, Gama C, Carter C, MacDonald A, Gold J, Silverstein S, Barch D. T68. DIFFERENT INFLUENCES OF INTELLECTUAL FUNCTIONING AND COGNITIVE PERFORMANCE TO FUNCTIONAL OUTCOMES IN SCHIZOPHRENIA AND HEALTHY CONTROLS Schizophrenia Bulletin. 44: S140-S140. DOI: 10.1093/Schbul/Sby016.344  0.643
2018 Waltz J, Demro C, Millman Z, Reeves G, Roiser J, Gold J, Schiffman J. 26.3 SALIENCE SIGNALING AND THE EMERGENCE OF PSYCHOPATHOLOGY IN YOUTH AT CLINICAL HIGH RISK FOR PSYCHOTIC ILLNESS Schizophrenia Bulletin. 44: S43-S43. DOI: 10.1093/Schbul/Sby014.108  0.586
2018 Oliver L, Haltigan J, Gold J, Foussias G, DeRosse P, Buchanan R, Malhotra A, Voineskos A. S189. Lower- and Higher-Level Factors of Social Cognition Relate to Neurocognition and Functional Outcome Across Schizophrenia Spectrum Disorders and Healthy Controls Biological Psychiatry. 83: S420-S421. DOI: 10.1016/J.Biopsych.2018.02.1081  0.465
2017 Leonard CJ, Robinson BM, Hahn B, Luck SJ, Gold JM. Altered spatial profile of distraction in people with schizophrenia. Journal of Abnormal Psychology. 126: 1077-1086. PMID 29154568 DOI: 10.1037/Abn0000314  0.699
2017 Gold JM, Robinson B, Leonard CJ, Hahn B, Chen S, McMahon RP, Luck SJ. Selective Attention, Working Memory, and Executive Function as Potential Independent Sources of Cognitive Dysfunction in Schizophrenia. Schizophrenia Bulletin. PMID 29140504 DOI: 10.1093/Schbul/Sbx155  0.754
2017 Reddy LF, Horan WP, Barch DM, Buchanan RW, Gold JM, Marder SR, Wynn JK, Young J, Green MF. Understanding the Association Between Negative Symptoms and Performance on Effort-Based Decision-Making Tasks: The Importance of Defeatist Performance Beliefs. Schizophrenia Bulletin. PMID 29140501 DOI: 10.1093/Schbul/Sbx156  0.44
2017 Barch DM, Gold JM, Kring AM. Paradigms for Assessing Hedonic Processing and Motivation in Humans: Relevance to Understanding Negative Symptoms in Psychopathology. Schizophrenia Bulletin. 43: 701-705. PMID 28969354 DOI: 10.1093/Schbul/Sbx063  0.354
2017 Rubin LH, Wehring HJ, Demyanovich H, Sue Carter C, Pournajafi-Nazarloo H, Feldman SM, Earl AK, August S, Gold JM, Kelly DL. Peripheral oxytocin and vasopressin are associated with clinical symptom severity and cognitive functioning in midlife women with chronic schizophrenia. Schizophrenia Research. PMID 28965776 DOI: 10.1016/J.Schres.2017.09.041  0.478
2017 Demro C, Rowland L, Wijtenburg SA, Waltz J, Gold J, Kline E, Thompson E, Reeves G, Hong LE, Schiffman J. Glutamatergic metabolites among adolescents at risk for psychosis. Psychiatry Research. 257: 179-185. PMID 28772136 DOI: 10.1016/J.Psychres.2017.07.040  0.621
2017 Erickson MA, Albrecht M, Ruffle A, Fleming L, Corlett P, Gold J. No association between symptom severity and MMN impairment in schizophrenia: A meta-analytic approach. Schizophrenia Research. Cognition. 9: 13-17. PMID 28740829 DOI: 10.1016/J.Scog.2017.05.002  0.665
2017 Ermel J, Carter CS, Gold JM, MacDonald AW, Daniel Ragland J, Silverstein SM, Strauss ME, Barch DM. Self versus informant reports on the specific levels of functioning scale: Relationships to depression and cognition in schizophrenia and schizoaffective disorder. Schizophrenia Research. Cognition. 9: 1-7. PMID 28740827 DOI: 10.1016/J.Scog.2017.04.001  0.619
2017 Erickson MA, Albrecht MA, Robinson B, Luck SJ, Gold JM. Impaired suppression of delay-period alpha and beta is associated with impaired working memory in schizophrenia. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 2: 272-279. PMID 28670630 DOI: 10.1016/J.Bpsc.2016.09.003  0.655
2017 Collins AGE, Albrecht MA, Waltz JA, Gold JM, Frank MJ. Interactions Among Working Memory, Reinforcement Learning, and Effort in Value-Based Choice: A New Paradigm and Selective Deficits in Schizophrenia. Biological Psychiatry. PMID 28651789 DOI: 10.1016/J.Biopsych.2017.05.017  0.67
2017 Buchanan RW, Kelly DL, Weiner E, Gold JM, Strauss GP, Koola MM, McMahon RP, Carpenter WT. A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia. Journal of Clinical Psychopharmacology. PMID 28590362 DOI: 10.1097/Jcp.0000000000000720  0.534
2017 Ray KL, Lesh TA, Howell AM, Salo TP, Ragland JD, MacDonald AW, Gold JM, Silverstein SM, Barch DM, Carter CS. Functional network changes and cognitive control in schizophrenia. Neuroimage. Clinical. 15: 161-170. PMID 28529872 DOI: 10.1016/J.Nicl.2017.05.001  0.652
2017 Strauss GP, Frost KH, Lee BG, Gold JM. THE POSITIVITY OFFSET THEORY OF ANHEDONIA IN SCHIZOPHRENIA. Clinical Psychological Science : a Journal of the Association For Psychological Science. 5: 226-238. PMID 28497008 DOI: 10.1177/2167702616674989  0.441
2017 Barch DM, Carter CS, Gold JM, Johnson SL, Kring AM, MacDonald AW, Pizzagalli DA, Ragland JD, Silverstein SM, Strauss ME. Explicit and Implicit Reinforcement Learning Across the Psychosis Spectrum. Journal of Abnormal Psychology. PMID 28406662 DOI: 10.1037/Abn0000259  0.65
2017 Kreither J, Lopez-Calderon J, Leonard CJ, Robinson BM, Ruffle A, Hahn B, Gold JM, Luck SJ. Electrophysiological Evidence for Hyperfocusing of Spatial Attention in Schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28283557 DOI: 10.1523/Jneurosci.3221-16.2017  0.761
2017 Hahn B, Harvey AN, Gold JM, Ross TJ, Stein EA. Load-dependent hyperdeactivation of the default mode network in people with schizophrenia. Schizophrenia Research. PMID 28073606 DOI: 10.1016/J.Schres.2017.01.001  0.497
2017 Bansal S, Robinson B, Leonard C, Frankovich K, Gold J, Luck S. Spatial recall performance: Differential landmark bias in schizophrenia Journal of Vision. 17: 1332. DOI: 10.1167/17.10.1332  0.787
2017 Leonard C, Robinson B, Hahn B, Luck S, Gold J. Saccadic evidence for spatial hyperfocusing in people with schizophrenia Journal of Vision. 17: 1328. DOI: 10.1167/17.10.1328  0.734
2017 Feldman S, Buchanan R, Carpenter W, McMahon R, Weiner E, Gold J, Adams H, Strauss G, Kelly D. SU17. Oxytocin and Sexual Function in Males and Females With Schizophrenia Schizophrenia Bulletin. 43: S167-S167. DOI: 10.1093/Schbul/Sbx024.016  0.384
2017 Chang WC, Lee VH, Chan SI, Waltz J, Gold J, Hui CL, Chan SK, Lee EH, Chen EY, Chan KWS. SA28. Reinforcement Learning Impairment Medication-Naive 
First-Episode Psychosis Patients Schizophrenia Bulletin. 43: S123-S123. DOI: 10.1093/Schbul/Sbx023.027  0.634
2017 Lee HC, Chang WC, Chan SI, Waltz J, Gold J, Hui CLM, Lee EHM, Chan SKW, Chen EYH. SA27. Reinforcement Learning Performance in Early Schizophrenia Patients and Their Nonpsychotic Siblings Schizophrenia Bulletin. 43: S122-S123. DOI: 10.1093/Schbul/Sbx023.026  0.721
2017 Rubin L, Demyanovich H, Wehring H, Carter S, Pournajafi-Nazarloo H, Maki P, Feldman S, Earl A, August S, Gold J, Kelly D. M27. Peripheral Oxytocin and Vasopressin are Associated With Clinical Symptom Severity and Cognitive Functioning in Midlife Women With Chronic Schizophrenia Schizophrenia Bulletin. 43: S221-S221. DOI: 10.1093/Schbul/Sbx022.026  0.477
2017 Gold J, Stankevich B, Robinson B, Ruffle A, Geng J, Leonard C, Luck S. 206. The Impact of Reward History on Allocation of Spatial Attention in Schizophrenia Schizophrenia Bulletin. 43: S105-S106. DOI: 10.1093/Schbul/Sbx021.284  0.743
2017 Waltz J, Xu Z, Brown E, Ruiz R, Gold J. 196. Schizophrenia Patients Show Enhanced Responses to Loss Avoidance in Frontostriatal Circuits Schizophrenia Bulletin. 43: S102-S102. DOI: 10.1093/Schbul/Sbx021.274  0.82
2017 Hernaus D, Xu Z, Brown E, Ruiz R, Frank M, Gold J, Waltz J. 147. Abnormal Frontal Cortical Activity During Rapid Flexible Decision-Making in Schizophrenia: Relationships With Motivational Deficits Schizophrenia Bulletin. 43: S77-S77. DOI: 10.1093/Schbul/Sbx021.205  0.822
2017 Buchanan R, Kelly D, Strauss G, Gold J, Weiner E, McMahon R, Holden J, Granholm E. 104. Combined CBSST and Oxytocin for Social Function in People With Schizophrenia Schizophrenia Bulletin. 43: S55-S55. DOI: 10.1093/Schbul/Sbx021.142  0.366
2017 Erickson M, Ruffle A, Fleming L, Corlett P, Gold J. 49. The Predictive Coding Account of Psychosis: A Meta-Analysis of the Relationship Between Mismatch Negativity and Symptom Severity Schizophrenia Bulletin. 43: S26-S26. DOI: 10.1093/Schbul/Sbx021.068  0.556
2017 MacDonald A, Patzelt E, Kurth-Nelson Z, Barch D, Carter C, Gold J, Ragland D, Silverstein S. 40. Exploration not Perseveration: Computational Modeling of Probabilistic Reversal Learning Impairments in Psychosis Schizophrenia Bulletin. 43: S22-S23. DOI: 10.1093/Schbul/Sbx021.059  0.535
2017 Ray K, MacDonald AW, Ragland JD, Gold J, Silverstein SM, Barch D, Carter C. 629. Dynamic Network Reorganization of the Frontal-Parietal, Aalience, and Default Mode Networks during Cognitive Control and Episodic Memory Biological Psychiatry. 81: S255. DOI: 10.1016/J.Biopsych.2017.02.499  0.519
2016 Albrecht MA, Waltz JA, Frank MJ, Gold JM. Probability and magnitude evaluation in schizophrenia. Schizophrenia Research. Cognition. 5: 41-46. PMID 28740816 DOI: 10.1016/J.Scog.2016.06.003  0.72
2016 Dowd EC, Frank MJ, Collins A, Gold JM, Barch DM. Probabilistic Reinforcement Learning in Patients With Schizophrenia: Relationships to Anhedonia and Avolition. Biological Psychiatry : Cognitive Neuroscience and Neuroimaging. 1: 460-473. PMID 27833939 DOI: 10.1016/J.Bpsc.2016.05.005  0.557
2016 Sawaki R, Kreither J, Leonard CJ, Kaiser ST, Hahn B, Gold JM, Luck SJ. Hyperfocusing of Attention on Goal-Related Information in Schizophrenia: Evidence From Electrophysiology. Journal of Abnormal Psychology. PMID 27709980 DOI: 10.1037/Abn0000209  0.74
2016 Reilly JL, Hill SK, Gold JM, Keefe RS, Clementz BA, Gershon E, Keshavan MS, Pearlson G, Tamminga CA, Sweeney JA. Impaired Context Processing is Attributable to Global Neuropsychological Impairment in Schizophrenia and Psychotic Bipolar Disorder. Schizophrenia Bulletin. PMID 27306316 DOI: 10.1093/Schbul/Sbw081  0.515
2016 Chang WC, Waltz JA, Gold JM, Chan TC, Chen EY. Mild Reinforcement Learning Deficits in Patients With First-Episode Psychosis. Schizophrenia Bulletin. PMID 27179125 DOI: 10.1093/Schbul/Sbw060  0.705
2016 Strauss GP, Gold JM. A Psychometric Comparison of the Clinical Assessment Interview for Negative Symptoms and the Brief Negative Symptom Scale. Schizophrenia Bulletin. PMID 27174556 DOI: 10.1093/Schbul/Sbw046  0.39
2016 Poppe AB, Barch DM, Carter CS, Gold JM, Ragland JD, Silverstein SM, MacDonald AW. Reduced Frontoparietal Activity in Schizophrenia Is Linked to a Specific Deficit in Goal Maintenance: A Multisite Functional Imaging Study. Schizophrenia Bulletin. PMID 27060129 DOI: 10.1093/Schbul/Sbw036  0.647
2016 Albrecht MA, Waltz JA, Cavanagh JF, Frank MJ, Gold JM. Reduction of Pavlovian Bias in Schizophrenia: Enhanced Effects in Clozapine-Administered Patients. Plos One. 11: e0152781. PMID 27044008 DOI: 10.1371/Journal.Pone.0152781  0.739
2016 Hahn B, Harvey AN, Gold JM, Fischer BA, Keller WR, Ross TJ, Stein EA. Hyperdeactivation of the Default Mode Network in People With Schizophrenia When Focusing Attention in Space. Schizophrenia Bulletin. PMID 26926831 DOI: 10.1093/Schbul/Sbw019  0.365
2016 Leonard C, Robinson B, Hahn B, Gold J, Luck S. Increased influence of previously attended features in people with schizophrenia Journal of Vision. 16: 424. DOI: 10.1167/16.12.424  0.41
2016 Beck V, Leonard C, Robinson B, Hahn B, Hollingworth A, Gold J, Luck S. People with Schizophrenia Demonstrate More Optimal Feature-Guided Visual Search in a Probabilistic Search Task Journal of Vision. 16: 338. DOI: 10.1167/16.12.338  0.826
2016 Albrecht MA, Waltz JA, Frank MJ, Gold JM. Probability and magnitude evaluation in schizophrenia Schizophrenia Research: Cognition. 5: 41-46. DOI: 10.1016/j.scog.2016.06.003  0.698
2015 Waltz JA, Demro C, Schiffman J, Thompson E, Kline E, Reeves G, Xu Z, Gold J. Reinforcement Learning Performance and Risk for Psychosis in Youth. The Journal of Nervous and Mental Disease. PMID 26588080 DOI: 10.1097/Nmd.0000000000000420  0.685
2015 McCleery A, Green MF, Hellemann GS, Baade LE, Gold JM, Keefe RS, Kern RS, Mesholam-Gately RI, Seidman LJ, Subotnik KL, Ventura J, Nuechterlein KH. Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB). Psychological Medicine. 1. PMID 26537981 DOI: 10.1017/S0033291715002433  0.482
2015 Lopez-Garcia P, Lesh TA, Salo T, Barch DM, MacDonald AW, Gold JM, Ragland JD, Strauss M, Silverstein SM, Carter CS. The neural circuitry supporting goal maintenance during cognitive control: a comparison of expectancy AX-CPT and dot probe expectancy paradigms. Cognitive, Affective & Behavioral Neuroscience. PMID 26494483 DOI: 10.3758/S13415-015-0384-1  0.622
2015 Sheffield JM, Repovs G, Harms MP, Carter CS, Gold JM, MacDonald AW, Ragland JD, Silverstein SM, Godwin D, Barch DM. Evidence for Accelerated Decline of Functional Brain Network Efficiency in Schizophrenia. Schizophrenia Bulletin. PMID 26472685 DOI: 10.1093/Schbul/Sbv148  0.635
2015 Erickson MA, Ruffle A, Gold JM. A Meta-Analysis of Mismatch Negativity in Schizophrenia: From Clinical Risk to Disease Specificity and Progression. Biological Psychiatry. PMID 26444073 DOI: 10.1016/J.Biopsych.2015.08.025  0.692
2015 Waltz JA, Gold JM. Motivational Deficits in Schizophrenia and the Representation of Expected Value. Current Topics in Behavioral Neurosciences. PMID 26370946 DOI: 10.1007/7854_2015_385  0.756
2015 Keefe RS, Haig GM, Marder SR, Harvey PD, Dunayevich E, Medalia A, Davidson M, Lombardo I, Bowie CR, Buchanan RW, Bugarski-Kirola D, Carpenter WT, Csernansky JT, Dago PL, Durand DM, ... ... Gold JM, et al. Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia. Schizophrenia Bulletin. PMID 26362273 DOI: 10.1093/Schbul/Sbv111  0.398
2015 Horan WP, Reddy LF, Barch DM, Buchanan RW, Dunayevich E, Gold JM, Marder SR, Wynn JK, Young JW, Green MF. Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 2-External Validity and Correlates. Schizophrenia Bulletin. PMID 26209546 DOI: 10.1093/Schbul/Sbv090  0.453
2015 Ragland JD, Ranganath C, Harms MP, Barch DM, Gold JM, Layher E, Lesh TA, MacDonald AW, Niendam TA, Phillips J, Silverstein SM, Yonelinas AP, Carter CS. Functional and Neuroanatomic Specificity of Episodic Memory Dysfunction in Schizophrenia: A Functional Magnetic Resonance Imaging Study of the Relational and Item-Specific Encoding Task. Jama Psychiatry. 72: 909-16. PMID 26200928 DOI: 10.1001/Jamapsychiatry.2015.0276  0.653
2015 Silverstein SM, Harms MP, Carter CS, Gold JM, Keane BP, MacDonald A, Daniel Ragland J, Barch DM. Cortical contributions to impaired contour integration in schizophrenia. Neuropsychologia. 75: 469-80. PMID 26160288 DOI: 10.1016/J.Neuropsychologia.2015.07.003  0.633
2015 Reddy LF, Horan WP, Barch DM, Buchanan RW, Dunayevich E, Gold JM, Lyons N, Marder SR, Treadway MT, Wynn JK, Young JW, Green MF. Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 1-Psychometric Characteristics of 5 Paradigms. Schizophrenia Bulletin. PMID 26142081 DOI: 10.1093/Schbul/Sbv089  0.555
2015 Green MF, Horan WP, Barch DM, Gold JM. Effort-Based Decision Making: A Novel Approach for Assessing Motivation in Schizophrenia. Schizophrenia Bulletin. PMID 26089350 DOI: 10.1093/Schbul/Sbv071  0.532
2015 Kelly DL, Sullivan KM, McEvoy JP, McMahon RP, Wehring HJ, Gold JM, Liu F, Warfel D, Vyas G, Richardson CM, Fischer BA, Keller WR, Koola MM, Feldman SM, Russ JC, et al. Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms. Journal of Clinical Psychopharmacology. 35: 374-81. PMID 26082974 DOI: 10.1097/Jcp.0000000000000345  0.492
2015 Gold JM, Waltz JA, Frank MJ. Effort Cost Computation in Schizophrenia: A Commentary on the Recent Literature. Biological Psychiatry. PMID 26049208 DOI: 10.1016/J.Biopsych.2015.05.005  0.731
2015 Culbreth AJ, Gold JM, Cools R, Barch DM. Impaired Activation in Cognitive Control Regions Predicts Reversal Learning in Schizophrenia. Schizophrenia Bulletin. PMID 26049083 DOI: 10.1093/Schbul/Sbv075  0.489
2015 Kristian Hill S, Buchholz A, Amsbaugh H, Reilly JL, Rubin LH, Gold JM, Keefe RS, Pearlson GD, Keshavan MS, Tamminga CA, Sweeney JA. Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment. Schizophrenia Research. 166: 310-5. PMID 26008884 DOI: 10.1016/J.Schres.2015.05.018  0.469
2015 Sheffield JM, Repovs G, Harms MP, Carter CS, Gold JM, MacDonald Iii AW, Daniel Ragland J, Silverstein SM, Godwin D, Barch DM. Fronto-parietal and cingulo-opercular network integrity and cognition in health and schizophrenia. Neuropsychologia. 73: 82-93. PMID 25979608 DOI: 10.1016/J.Neuropsychologia.2015.05.006  0.452
2015 Brown EC, Hack SM, Gold JM, Carpenter WT, Fischer BA, Prentice KP, Waltz JA. Integrating frequency and magnitude information in decision-making in schizophrenia: An account of patient performance on the Iowa Gambling Task. Journal of Psychiatric Research. 66: 16-23. PMID 25959618 DOI: 10.1016/J.Jpsychires.2015.04.007  0.834
2015 McCleery A, Green MF, Hellemann GS, Baade LE, Gold JM, Keefe RS, Kern RS, Mesholam-Gately RI, Seidman LJ, Subotnik KL, Ventura J, Nuechterlein KH. Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB). Psychological Medicine. 1-10. PMID 25916421 DOI: 10.1017/S0033291715000641  0.413
2015 Waltz JA, Brown JK, Gold JM, Ross TJ, Salmeron BJ, Stein EA. Probing the Dynamic Updating of Value in Schizophrenia Using a Sensory-Specific Satiety Paradigm. Schizophrenia Bulletin. PMID 25834028 DOI: 10.1093/Schbul/Sbv034  0.749
2015 Strauss GP, Keller WR, Koenig JI, Gold JM, Frost KH, Buchanan RW. Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia. Schizophrenia Research. 162: 47-51. PMID 25673435 DOI: 10.1016/J.Schres.2015.01.034  0.387
2015 Strauss GP, Keller WR, Koenig JI, Sullivan SK, Gold JM, Buchanan RW. Endogenous oxytocin levels are associated with the perception of emotion in dynamic body expressions in schizophrenia. Schizophrenia Research. 162: 52-6. PMID 25620121 DOI: 10.1016/J.Schres.2015.01.022  0.388
2015 Morra LF, Gold JM, Sullivan SK, Strauss GP. Predictors of neuropsychological effort test performance in schizophrenia. Schizophrenia Research. 162: 205-10. PMID 25583248 DOI: 10.1016/J.Schres.2014.12.033  0.562
2015 Strauss GP, Keller WR, Koenig JI, Gold JM, Ossenfort KL, Buchanan RW. Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia. Schizophrenia Research. 162: 57-61. PMID 25583247 DOI: 10.1016/J.Schres.2014.12.023  0.508
2015 Strauss GP, Kappenman ES, Culbreth AJ, Catalano LT, Ossenfort KL, Lee BG, Gold JM. Emotion regulation abnormalities in schizophrenia: Directed attention strategies fail to decrease the neurophysiological response to unpleasant stimuli. Journal of Abnormal Psychology. 124: 288-301. PMID 25486078 DOI: 10.1037/Abn0000017  0.376
2015 Buchanan RW, Weiner E, Kelly DL, Gold JM, Keller WR, Waltz JA, McMahon RP, Gorelick DA. Rasagiline in the Treatment of the Persistent Negative Symptoms of Schizophrenia. Schizophrenia Bulletin. 41: 900-8. PMID 25368372 DOI: 10.1093/Schbul/Sbu151  0.667
2015 Erickson MA, Hahn B, Leonard CJ, Robinson B, Gray B, Luck SJ, Gold J. Impaired working memory capacity is not caused by failures of selective attention in schizophrenia. Schizophrenia Bulletin. 41: 366-73. PMID 25031223 DOI: 10.1093/Schbul/Sbu101  0.806
2015 Strauss GP, Morra LF, Sullivan SK, Gold JM. The role of low cognitive effort and negative symptoms in neuropsychological impairment in schizophrenia. Neuropsychology. 29: 282-91. PMID 25000322 DOI: 10.1037/Neu0000113  0.511
2015 Gold JM, Kool W, Botvinick MM, Hubzin L, August S, Waltz JA. Cognitive effort avoidance and detection in people with schizophrenia. Cognitive, Affective & Behavioral Neuroscience. 15: 145-54. PMID 24957405 DOI: 10.3758/S13415-014-0308-5  0.748
2015 Kelly D, Buchanan R, McMahon R, Gold J, Feldman S, August S, Sullivan K, Osing J, Carpenter W. S.13.04 Effects of intranasal oxytocin or galantamine for primary enduring negative symptoms and cognitive impairments in people with schizophrenia European Neuropsychopharmacology. 25: S131. DOI: 10.1016/S0924-977X(15)30071-7  0.53
2015 Silverstein SM, Harms MP, Carter CS, Gold JM, Keane BP, MacDonald A, Daniel Ragland J, Barch DM. Cortical contributions to impaired contour integration in schizophrenia Neuropsychologia. 75: 469-480. DOI: 10.1016/j.neuropsychologia.2015.07.003  0.624
2015 Ragland JD, Ranganath C, Harms MP, Barch DM, Gold JM, Layher E, Lesh TA, MacDonald AW, Niendam TA, Phillips J, Silverstein SM, Yonelinas AP, Carter CS. Functional and neuroanatomic specificity of episodic memory dysfunction in schizophrenia: A functional magnetic resonance imaging study of the relational and item-specific encoding task Jama Psychiatry. 72: 909-916. DOI: 10.1001/jamapsychiatry.2015.0276  0.578
2014 Erickson M, Hahn B, Leonard C, Robinson B, Luck S, Gold J. Enhanced vulnerability to distraction does not account for working memory capacity reduction in people with schizophrenia. Schizophrenia Research. Cognition. 1: 149-154. PMID 25705590 DOI: 10.1016/J.Scog.2014.09.001  0.807
2014 Wonodi I, McMahon RP, Krishna N, Mitchell BD, Liu J, Glassman M, Hong LE, Gold JM. Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia. Schizophrenia Research. 160: 80-7. PMID 25464917 DOI: 10.1016/J.Schres.2014.10.026  0.528
2014 Collins AG, Brown JK, Gold JM, Waltz JA, Frank MJ. Working memory contributions to reinforcement learning impairments in schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 13747-56. PMID 25297101 DOI: 10.1523/Jneurosci.0989-14.2014  0.78
2014 Sullivan S, Strauss G, Ossenfort K, Katz A, Gold J. C-83The Role of IQ in Effort Test Performance in Schizophrenia. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 29: 604. PMID 25176926 DOI: 10.1093/Arclin/Acu038.264  0.483
2014 Morra L, Gold J, Ossenfort K, Strauss G. C-78Predicting Insufficient Effort in Schizophrenia using the Repeated Battery for the Assessment of Neuropsychological Status Effort Index. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 29: 602-3. PMID 25176921 DOI: 10.1093/Arclin/Acu038.259  0.473
2014 Ossenfort K, Frost K, Katz A, Chiu I, Strauss G, Gold J. C-18Negative Symptoms Predict Neuropsychological Impairment in Schizophrenia. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 29: 579. PMID 25176861 DOI: 10.1093/Arclin/Acu038.199  0.51
2014 Frost K, Keller W, Buchanan R, Gold J, Koenig J, Ossenfort K, Katz A, Strauss G. C-14Plasma Oxytocin Levels are Associated with Impaired Social Cognition and Neurocognition in Schizophrenia. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 29: 577-8. PMID 25176857 DOI: 10.1093/Arclin/Acu038.195  0.458
2014 Katz A, Chui I, Powell M, Varuzza G, Gold J, Strauss G. C-08Impaired Cognitive Control and Goal Maintenance in Schizophrenia. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 29: 575. PMID 25176851 DOI: 10.1093/Arclin/Acu038.189  0.518
2014 Gray BE, McMahon RP, Green MF, Seidman LJ, Mesholam-Gately RI, Kern RS, Nuechterlein KH, Keefe RS, Gold JM. Detecting reliable cognitive change in individual patients with the MATRICS Consensus Cognitive Battery. Schizophrenia Research. 159: 182-7. PMID 25156338 DOI: 10.1016/J.Schres.2014.07.032  0.311
2014 Luck SJ, McClenon C, Beck VM, Hollingworth A, Leonard CJ, Hahn B, Robinson BM, Gold JM. Hyperfocusing in schizophrenia: Evidence from interactions between working memory and eye movements. Journal of Abnormal Psychology. 123: 783-95. PMID 25089655 DOI: 10.1037/Abn0000003  0.828
2014 Kiwanuka JN, Strauss GP, McMahon RP, Gold JM. Psychological predictors of functional outcome in people with schizophrenia. Schizophrenia Research. 157: 299-304. PMID 24878429 DOI: 10.1016/J.Schres.2014.04.030  0.481
2014 Gray BE, Hahn B, Robinson B, Harvey A, Leonard CJ, Luck SJ, Gold JM. Relationships between divided attention and working memory impairment in people with schizophrenia. Schizophrenia Bulletin. 40: 1462-71. PMID 24748559 DOI: 10.1093/Schbul/Sbu015  0.769
2014 Leonard CJ, Robinson BM, Hahn B, Gold JM, Luck SJ. Enhanced distraction by magnocellular salience signals in schizophrenia. Neuropsychologia. 56: 359-66. PMID 24561035 DOI: 10.1016/J.Neuropsychologia.2014.02.011  0.771
2014 Doll BB, Waltz JA, Cockburn J, Brown JK, Frank MJ, Gold JM. Reduced susceptibility to confirmation bias in schizophrenia. Cognitive, Affective & Behavioral Neuroscience. 14: 715-28. PMID 24481852 DOI: 10.3758/S13415-014-0250-6  0.745
2014 Strauss GP, Waltz JA, Gold JM. A review of reward processing and motivational impairment in schizophrenia. Schizophrenia Bulletin. 40: S107-16. PMID 24375459 DOI: 10.1093/Schbul/Sbt197  0.69
2014 Sheffield JM, Gold JM, Strauss ME, Carter CS, MacDonald AW, Ragland JD, Silverstein SM, Barch DM. Common and specific cognitive deficits in schizophrenia: relationships to function. Cognitive, Affective & Behavioral Neuroscience. 14: 161-74. PMID 24037621 DOI: 10.3758/S13415-013-0211-5  0.686
2014 Strauss ME, McLouth CJ, Barch DM, Carter CS, Gold JM, Luck SJ, MacDonald AW, Ragland JD, Ranganath C, Keane BP, Silverstein SM. Temporal stability and moderating effects of age and sex on CNTRaCS task performance. Schizophrenia Bulletin. 40: 835-44. PMID 23817024 DOI: 10.1093/Schbul/Sbt089  0.654
2014 Reddy F, Horan WP, Wynn J, Corey-Lisle P, Maglinte G, Barch D, Buchanan RW, Buchanan RW, Gold J, Young JW, Green M. Poster #M167 ASSESSING EFFORT-BASED DECISION-MAKING IN SCHIZOPHRENIA WITH TWO NOVEL BEHAVIORAL PARADIGMS Schizophrenia Research. 153: S251. DOI: 10.1016/S0920-9964(14)70717-0  0.428
2014 Chan TCW, Chang W, Gold J, Waltz J, Hui C, Chan K, Lee H, Chen E. Poster #M84 REWARD LEARNING IMPAIRMENT IN PATIENTS WITH FIRST-EPISODE SCHIZOPHRENIA-SPECTRUM DISORDER Schizophrenia Research. 153: S220. DOI: 10.1016/S0920-9964(14)70634-6  0.733
2014 Kelly DL, Sullivan KM, Wehring HJ, McEvoy JP, Keefe R, McMahon RP, Gold JM, Feldman S, Warfel C, Kearns AM, Osing J, Russ J, Vyas G, Richardson CM, August S, et al. Adjunctive Minocycline In Clozapine Treated Schizophrenia Patients Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70257-9  0.522
2014 Barch DM, Carter C, Gold J, Harms M, MacDonald A, Poppe A, Ragland J, Silverstein S, Strauss M. NEW NEUROSCIENCE BASED COGNITIVE PARADIGMS FOR BIOMARKER RESEARCH IN SCHIZOPHRENIA Schizophrenia Research. 153: S13. DOI: 10.1016/S0920-9964(14)70040-4  0.652
2013 Leonard CJ, Robinson BM, Kaiser ST, Hahn B, McClenon C, Harvey AN, Luck SJ, Gold JM. Testing sensory and cognitive explanations of the antisaccade deficit in schizophrenia. Journal of Abnormal Psychology. 122: 1111-20. PMID 24364614 DOI: 10.1037/A0034956  0.722
2013 Hill SK, Reilly JL, Keefe RS, Gold JM, Bishop JR, Gershon ES, Tamminga CA, Pearlson GD, Keshavan MS, Sweeney JA. Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. The American Journal of Psychiatry. 170: 1275-84. PMID 23771174 DOI: 10.1176/Appi.Ajp.2013.12101298  0.405
2013 Brown JK, Waltz JA, Strauss GP, McMahon RP, Frank MJ, Gold JM. Hypothetical decision making in schizophrenia: the role of expected value computation and "irrational" biases. Psychiatry Research. 209: 142-9. PMID 23664664 DOI: 10.1016/J.Psychres.2013.02.034  0.777
2013 Gray BE, McMahon RP, Gold JM. General intellectual ability does not explain the general deficit in schizophrenia. Schizophrenia Research. 147: 315-9. PMID 23664590 DOI: 10.1016/J.Schres.2013.04.016  0.561
2013 Hahn B, Harvey AN, Concheiro-Guisan M, Huestis MA, Holcomb HH, Gold JM. A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia. Biological Psychiatry. 74: 436-43. PMID 23660272 DOI: 10.1016/J.Biopsych.2013.03.017  0.383
2013 Johnson MK, McMahon RP, Robinson BM, Harvey AN, Hahn B, Leonard CJ, Luck SJ, Gold JM. The relationship between working memory capacity and broad measures of cognitive ability in healthy adults and people with schizophrenia. Neuropsychology. 27: 220-9. PMID 23527650 DOI: 10.1037/A0032060  0.732
2013 Owoso A, Carter CS, Gold JM, MacDonald AW, Ragland JD, Silverstein SM, Strauss ME, Barch DM. Cognition in schizophrenia and schizo-affective disorder: impairments that are more similar than different. Psychological Medicine. 43: 2535-45. PMID 23522057 DOI: 10.1017/S0033291713000536  0.682
2013 Waltz JA, Kasanova Z, Ross TJ, Salmeron BJ, McMahon RP, Gold JM, Stein EA. The roles of reward, default, and executive control networks in set-shifting impairments in schizophrenia. Plos One. 8: e57257. PMID 23468948 DOI: 10.1371/Journal.Pone.0057257  0.741
2013 Strauss GP, Catalano LT, Llerena K, Gold JM. The processing of emotional stimuli during periods of limited attentional resources in schizophrenia. Journal of Abnormal Psychology. 122: 492-505. PMID 23421529 DOI: 10.1037/A0031212  0.396
2013 Gold JM, Strauss GP, Waltz JA, Robinson BM, Brown JK, Frank MJ. Negative symptoms of schizophrenia are associated with abnormal effort-cost computations. Biological Psychiatry. 74: 130-6. PMID 23394903 DOI: 10.1016/J.Biopsych.2012.12.022  0.747
2013 Strauss GP, Kappenman ES, Culbreth AJ, Catalano LT, Lee BG, Gold JM. Emotion regulation abnormalities in schizophrenia: cognitive change strategies fail to decrease the neural response to unpleasant stimuli. Schizophrenia Bulletin. 39: 872-83. PMID 23314192 DOI: 10.1093/Schbul/Sbs186  0.375
2013 Gold JM, Dickinson D. "Generalized cognitive deficit" in schizophrenia: overused or underappreciated? Schizophrenia Bulletin. 39: 263-5. PMID 23211397 DOI: 10.1093/Schbul/Sbs143  0.563
2013 Hahn B, Gold JM, Buchanan RW. The potential of nicotinic enhancement of cognitive remediation training in schizophrenia. Neuropharmacology. 64: 185-90. PMID 22705396 DOI: 10.1016/J.Neuropharm.2012.05.050  0.455
2013 Leonard CJ, Kaiser ST, Robinson BM, Kappenman ES, Hahn B, Gold JM, Luck SJ. Toward the neural mechanisms of reduced working memory capacity in schizophrenia. Cerebral Cortex (New York, N.Y. : 1991). 23: 1582-92. PMID 22661407 DOI: 10.1093/Cercor/Bhs148  0.724
2012 Strauss GP, Keller WR, Buchanan RW, Gold JM, Fischer BA, McMahon RP, Catalano LT, Culbreth AJ, Carpenter WT, Kirkpatrick B. Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale. Schizophrenia Research. 142: 88-92. PMID 23127378 DOI: 10.1016/J.Schres.2012.10.012  0.389
2012 Knowles EE, Weiser M, David AS, Dickinson D, Glahn D, Gold J, Davidson M, Reichenberg A. Dedifferentiation and substitute strategy: deconstructing the processing-speed impairment in schizophrenia. Schizophrenia Research. 142: 129-36. PMID 23084540 DOI: 10.1016/J.Schres.2012.08.020  0.514
2012 Strauss GP, Hong LE, Gold JM, Buchanan RW, McMahon RP, Keller WR, Fischer BA, Catalano LT, Culbreth AJ, Carpenter WT, Kirkpatrick B. Factor structure of the Brief Negative Symptom Scale. Schizophrenia Research. 142: 96-8. PMID 23062750 DOI: 10.1016/J.Schres.2012.09.007  0.368
2012 Strauss GP, Lee BG, Waltz JA, Robinson BM, Brown JK, Gold JM. Cognition-emotion interactions are modulated by working memory capacity in individuals with schizophrenia. Schizophrenia Research. 141: 257-61. PMID 22968207 DOI: 10.1016/J.Schres.2012.08.010  0.781
2012 Keane BP, Silverstein SM, Barch DM, Carter CS, Gold JM, Kovács I, MacDonald AW, Ragland JD, Strauss ME. The spatial range of contour integration deficits in schizophrenia. Experimental Brain Research. 220: 251-9. PMID 22710617 DOI: 10.1007/S00221-012-3134-4  0.655
2012 Hahn B, Robinson BM, Kaiser ST, Matveeva TM, Harvey AN, Luck SJ, Gold JM. Kraepelin and Bleuler had it right: people with schizophrenia have deficits sustaining attention over time. Journal of Abnormal Psychology. 121: 641-8. PMID 22686867 DOI: 10.1037/A0028492  0.52
2012 Harvey PD, Heaton RK, Carpenter WT, Green MF, Gold JM, Schoenbaum M. Functional impairment in people with schizophrenia: focus on employability and eligibility for disability compensation. Schizophrenia Research. 140: 1-8. PMID 22503642 DOI: 10.1016/J.Schres.2012.03.025  0.521
2012 Harvey PD, Heaton RK, Carpenter WT, Green MF, Gold JM, Schoenbaum M. Diagnosis of schizophrenia: consistency across information sources and stability of the condition. Schizophrenia Research. 140: 9-14. PMID 22503641 DOI: 10.1016/J.Schres.2012.03.026  0.46
2012 Strauss GP, Gold JM. A new perspective on anhedonia in schizophrenia. The American Journal of Psychiatry. 169: 364-73. PMID 22407079 DOI: 10.1176/Appi.Ajp.2011.11030447  0.427
2012 Gold JM, Waltz JA, Matveeva TM, Kasanova Z, Strauss GP, Herbener ES, Collins AG, Frank MJ. Negative symptoms and the failure to represent the expected reward value of actions: behavioral and computational modeling evidence. Archives of General Psychiatry. 69: 129-38. PMID 22310503 DOI: 10.1001/Archgenpsychiatry.2011.1269  0.691
2012 Henderson D, Poppe AB, Barch DM, Carter CS, Gold JM, Ragland JD, Silverstein SM, Strauss ME, MacDonald AW. Optimization of a goal maintenance task for use in clinical applications. Schizophrenia Bulletin. 38: 104-13. PMID 22199092 DOI: 10.1093/Schbul/Sbr172  0.597
2012 Gold J. Cognitive neuroscience test reliability and clinical applications for schizophrenia. Schizophrenia Bulletin. 38: 103. PMID 22199091 DOI: 10.1093/Schbul/Sbr173  0.518
2012 Javitt DC, Buchanan RW, Keefe RS, Kern R, McMahon RP, Green MF, Lieberman J, Goff DC, Csernansky JG, McEvoy JP, Jarskog F, Seidman LJ, Gold JM, Kimhy D, Nolan KS, et al. Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophrenia Research. 136: 25-31. PMID 22169248 DOI: 10.1016/J.Schres.2011.11.001  0.494
2012 Boggs DL, Kelly DL, McMahon RP, Gold JM, Gorelick DA, Linthicum J, Conley RR, Liu F, Waltz J, Huestis MA, Buchanan RW. Rimonabant for neurocognition in schizophrenia: a 16-week double blind randomized placebo controlled trial. Schizophrenia Research. 134: 207-10. PMID 22137462 DOI: 10.1016/J.Schres.2011.11.009  0.712
2012 Ragland JD, Ranganath C, Barch DM, Gold JM, Haley B, MacDonald AW, Silverstein SM, Strauss ME, Yonelinas AP, Carter CS. Relational and Item-Specific Encoding (RISE): task development and psychometric characteristics. Schizophrenia Bulletin. 38: 114-24. PMID 22124089 DOI: 10.1093/Schbul/Sbr146  0.636
2012 Barch DM, Carter CS, Dakin SC, Gold J, Luck SJ, Macdonald A, Ragland JD, Silverstein S, Strauss ME. The clinical translation of a measure of gain control: the contrast-contrast effect task. Schizophrenia Bulletin. 38: 135-43. PMID 22101963 DOI: 10.1093/Schbul/Sbr154  0.675
2012 Gold JM, Barch DM, Carter CS, Dakin S, Luck SJ, MacDonald AW, Ragland JD, Ranganath C, Kovacs I, Silverstein SM, Strauss M. Clinical, functional, and intertask correlations of measures developed by the Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia Consortium. Schizophrenia Bulletin. 38: 144-52. PMID 22101961 DOI: 10.1093/Schbul/Sbr142  0.67
2012 August SM, Kiwanuka JN, McMahon RP, Gold JM. The MATRICS Consensus Cognitive Battery (MCCB): clinical and cognitive correlates. Schizophrenia Research. 134: 76-82. PMID 22093182 DOI: 10.1016/J.Schres.2011.10.015  0.477
2012 Kappenman ES, Kaiser ST, Robinson BM, Morris SE, Hahn B, Beck VM, Leonard CJ, Gold JM, Luck SJ. Response activation impairments in schizophrenia: evidence from the lateralized readiness potential. Psychophysiology. 49: 73-84. PMID 22091661 DOI: 10.1111/J.1469-8986.2011.01288.X  0.819
2012 Hahn B, Hollingworth A, Robinson BM, Kaiser ST, Leonard CJ, Beck VM, Kappenman ES, Luck SJ, Gold JM. Control of working memory content in schizophrenia. Schizophrenia Research. 134: 70-5. PMID 22079944 DOI: 10.1016/J.Schres.2011.10.008  0.808
2012 Silverstein SM, Keane BP, Barch DM, Carter CS, Gold JM, Kovács I, MacDonald A, Ragland JD, Strauss ME. Optimization and validation of a visual integration test for schizophrenia research. Schizophrenia Bulletin. 38: 125-34. PMID 22021658 DOI: 10.1093/Schbul/Sbr141  0.656
2012 Hahn B, Robinson BM, Harvey AN, Kaiser ST, Leonard CJ, Luck SJ, Gold JM. Visuospatial attention in schizophrenia: deficits in broad monitoring. Journal of Abnormal Psychology. 121: 119-28. PMID 21604825 DOI: 10.1037/A0023938  0.708
2012 Silverstein SM, Keane BP, Barch DM, Carter CS, Gold JM, Kovacs I, MacDonald A, Ragland JD, Strauss ME. Test-Retest Reliability of a Contour Integration Test in Samples of Healthy Control and Schizophrenia Subjects Journal of Vision. 12: 891-891. DOI: 10.1167/12.9.891  0.608
2012 Strauss GP, Catalano LT, Gold JM. Poster #68 A NEW PERSPECTIVE ON ANHEDONIA IN SCHIZOPHRENIA Schizophrenia Research. 136: S305. DOI: 10.1016/S0920-9964(12)70901-5  0.511
2012 Strauss GP, Gold JM, Cohen AS. Response to Gooding and Plfum, "The nature of diminished pleasure in individuals at risk for or affected by schizophrenia". Anticipatory and consummatory pleasure deficits across the schizophrenia spectrum Psychiatry Research. 198: 174-175. DOI: 10.1016/J.Psychres.2012.06.040  0.544
2011 Morris SE, Holroyd CB, Mann-Wrobel MC, Gold JM. Dissociation of response and feedback negativity in schizophrenia: electrophysiological and computational evidence for a deficit in the representation of value. Frontiers in Human Neuroscience. 5: 123. PMID 22065618 DOI: 10.3389/Fnhum.2011.00123  0.518
2011 Strauss GP, Llerena K, Gold JM. Attentional disengagement from emotional stimuli in schizophrenia. Schizophrenia Research. 131: 219-23. PMID 21703824 DOI: 10.1016/J.Schres.2011.06.001  0.49
2011 Reise SP, Ventura J, Keefe RS, Baade LE, Gold JM, Green MF, Kern RS, Mesholam-Gately R, Nuechterlein KH, Seidman LJ, Bilder R. Bifactor and item response theory analyses of interviewer report scales of cognitive impairment in schizophrenia. Psychological Assessment. 23: 245-61. PMID 21381848 DOI: 10.1037/A0021501  0.459
2011 Gold JM. Imaging emotion in schizophrenia: not finding feelings in all the right places. The American Journal of Psychiatry. 168: 237-9. PMID 21368303 DOI: 10.1176/Appi.Ajp.2010.10111653  0.427
2011 Strauss GP, Wilbur RC, Warren KR, August SM, Gold JM. Anticipatory vs. consummatory pleasure: what is the nature of hedonic deficits in schizophrenia? Psychiatry Research. 187: 36-41. PMID 21295860 DOI: 10.1016/J.Psychres.2011.01.012  0.513
2011 Kasanova Z, Waltz JA, Strauss GP, Frank MJ, Gold JM. Optimizing vs. matching: response strategy in a probabilistic learning task is associated with negative symptoms of schizophrenia. Schizophrenia Research. 127: 215-22. PMID 21239143 DOI: 10.1016/J.Schres.2010.12.003  0.7
2011 Heerey EA, Matveeva TM, Gold JM. Imagining the future: degraded representations of future rewards and events in schizophrenia. Journal of Abnormal Psychology. 120: 483-9. PMID 21171727 DOI: 10.1037/A0021810  0.605
2011 Strauss GP, Frank MJ, Waltz JA, Kasanova Z, Herbener ES, Gold JM. Deficits in positive reinforcement learning and uncertainty-driven exploration are associated with distinct aspects of negative symptoms in schizophrenia. Biological Psychiatry. 69: 424-31. PMID 21168124 DOI: 10.1016/J.Biopsych.2010.10.015  0.735
2011 Kern RS, Gold JM, Dickinson D, Green MF, Nuechterlein KH, Baade LE, Keefe RS, Mesholam-Gately RI, Seidman LJ, Lee C, Sugar CA, Marder SR. The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. Schizophrenia Research. 126: 124-31. PMID 21159492 DOI: 10.1016/J.Schres.2010.11.008  0.484
2011 Buchanan RW, Keefe RS, Lieberman JA, Barch DM, Csernansky JG, Goff DC, Gold JM, Green MF, Jarskog LF, Javitt DC, Kimhy D, Kraus MS, McEvoy JP, Mesholam-Gately RI, Seidman LJ, et al. A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biological Psychiatry. 69: 442-9. PMID 21145041 DOI: 10.1016/J.Biopsych.2010.09.052  0.532
2011 Waltz JA, Frank MJ, Wiecki TV, Gold JM. Altered probabilistic learning and response biases in schizophrenia: behavioral evidence and neurocomputational modeling. Neuropsychology. 25: 86-97. PMID 21090899 DOI: 10.1037/A0020882  0.689
2011 Wisner KM, ElvevÃ¥g B, Gold JM, Weinberger DR, Dickinson D. A closer look at siblings of patients with schizophrenia: the association of depression history and sex with cognitive phenotypes. Schizophrenia Research. 126: 164-73. PMID 21030214 DOI: 10.1016/J.Schres.2010.09.011  0.421
2011 Strauss GP, Robinson BM, Waltz JA, Frank MJ, Kasanova Z, Herbener ES, Gold JM. Patients with schizophrenia demonstrate inconsistent preference judgments for affective and nonaffective stimuli. Schizophrenia Bulletin. 37: 1295-304. PMID 20484522 DOI: 10.1093/Schbul/Sbq047  0.675
2011 Dickinson D, Goldberg TE, Gold JM, Elvevåg B, Weinberger DR. Cognitive factor structure and invariance in people with schizophrenia, their unaffected siblings, and controls. Schizophrenia Bulletin. 37: 1157-67. PMID 20351040 DOI: 10.1093/Schbul/Sbq018  0.524
2011 Hahn B, Kappenman ES, Robinson BM, Fuller RL, Luck SJ, Gold JM. Iconic decay in schizophrenia. Schizophrenia Bulletin. 37: 950-7. PMID 20053864 DOI: 10.1093/Schbul/Sbp164  0.502
2011 Gold JM. Is cognitive impairment in schizophrenia ready for diagnostic prime time? World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 7: 32-3. PMID 18458780 DOI: 10.1002/J.2051-5545.2008.Tb00145.X  0.538
2011 Goldberg TE, David A, Gold JM. Neurocognitive Impairments in Schizophrenia: Their Character and Role in Symptom Formation Schizophrenia: Third Edition. 142-162. DOI: 10.1002/9781444327298.ch8  0.431
2010 Waltz JA, Schweitzer JB, Ross TJ, Kurup PK, Salmeron BJ, Rose EJ, Gold JM, Stein EA. Abnormal responses to monetary outcomes in cortex, but not in the basal ganglia, in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2427-39. PMID 20720534 DOI: 10.1038/Npp.2010.126  0.782
2010 Weiner E, Conley RR, Ball MP, Feldman S, Gold JM, Kelly DL, Wonodi I, McMahon RP, Buchanan RW. Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2274-83. PMID 20664583 DOI: 10.1038/Npp.2010.101  0.384
2010 Hahn B, Robinson BM, Kaiser ST, Harvey AN, Beck VM, Leonard CJ, Kappenman ES, Luck SJ, Gold JM. Failure of schizophrenia patients to overcome salient distractors during working memory encoding. Biological Psychiatry. 68: 603-9. PMID 20570242 DOI: 10.1016/J.Biopsych.2010.04.014  0.848
2010 Ventura J, Reise SP, Keefe RS, Baade LE, Gold JM, Green MF, Kern RS, Mesholam-Gately R, Nuechterlein KH, Seidman LJ, Bilder RM. The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognition. Schizophrenia Research. 121: 24-31. PMID 20542412 DOI: 10.1016/J.Schres.2010.04.016  0.435
2010 Gold JM, Hahn B, Zhang WW, Robinson BM, Kappenman ES, Beck VM, Luck SJ. Reduced capacity but spared precision and maintenance of working memory representations in schizophrenia. Archives of General Psychiatry. 67: 570-7. PMID 20530006 DOI: 10.1001/Archgenpsychiatry.2010.65  0.809
2010 Longenecker J, Genderson J, Dickinson D, Malley J, Elvevåg B, Weinberger DR, Gold J. Where have all the women gone?: participant gender in epidemiological and non-epidemiological research of schizophrenia. Schizophrenia Research. 119: 240-5. PMID 20399612 DOI: 10.1016/J.Schres.2010.03.023  0.377
2010 Dickinson D, Tenhula W, Morris S, Brown C, Peer J, Spencer K, Li L, Gold JM, Bellack AS. A randomized, controlled trial of computer-assisted cognitive remediation for schizophrenia. The American Journal of Psychiatry. 167: 170-80. PMID 20008941 DOI: 10.1176/Appi.Ajp.2009.09020264  0.499
2010 Kern RS, Gold JM, Dickinson D, Green MF, Nuechterlein KH, Keefe RS, Marder SR, Sugar CA. COGNITIVE DYSFUNCTION AND COMMUNITY FUNCTIONING IN SCHIZOPHRENIA: RESULTS FROM THE MATRICS PSYCHOMETRIC AND STANDARDIZATION STUDY (PASS) Schizophrenia Research. 117: 323-324. DOI: 10.1016/J.Schres.2010.02.551  0.496
2010 Buchanan RW, Barch D, Csernansky J, Goff D, Gold J, Jarskog F, Javitt D, Keefe R, Lieberman J, McEvoy J, McMahon R, Marder S. MK-0777 FOR THE TREATMENT OF COGNITIVE IMPAIRMENTS IN PEOPLE WITH SCHIZOPHRENIA Schizophrenia Research. 117: 119. DOI: 10.1016/J.Schres.2010.02.053  0.517
2009 Gold JM, Hahn B, Strauss GP, Waltz JA. Turning it upside down: areas of preserved cognitive function in schizophrenia. Neuropsychology Review. 19: 294-311. PMID 19452280 DOI: 10.1007/S11065-009-9098-X  0.747
2009 Shapiro DI, Marenco S, Spoor EH, Egan MF, Weinberger DR, Gold JM. The Premorbid Adjustment Scale as a measure of developmental compromise in patients with schizophrenia and their healthy siblings. Schizophrenia Research. 112: 136-42. PMID 19410430 DOI: 10.1016/J.Schres.2009.04.007  0.397
2009 Luck SJ, Kappenman ES, Fuller RL, Robinson B, Summerfelt A, Gold JM. Impaired response selection in schizophrenia: evidence from the P3 wave and the lateralized readiness potential. Psychophysiology. 46: 776-86. PMID 19386044 DOI: 10.1111/J.1469-8986.2009.00817.X  0.474
2009 Kelly DL, Buchanan RW, Boggs DL, McMahon RP, Dickinson D, Nelson M, Gold JM, Ball MP, Feldman S, Liu F, Conley RR. A randomized double-blind trial of atomoxetine for cognitive impairments in 32 people with schizophrenia. The Journal of Clinical Psychiatry. 70: 518-25. PMID 19358788 DOI: 10.4088/Jcp.08M04358  0.545
2009 Fuller RL, Luck SJ, Braun EL, Robinson BM, McMahon RP, Gold JM. Impaired visual working memory consolidation in schizophrenia. Neuropsychology. 23: 71-80. PMID 19210034 DOI: 10.1037/A0013854  0.527
2009 Waltz JA, Schweitzer JB, Gold JM, Kurup PK, Ross TJ, Salmeron BJ, Rose EJ, McClure SM, Stein EA. Patients with schizophrenia have a reduced neural response to both unpredictable and predictable primary reinforcers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1567-77. PMID 19052540 DOI: 10.1038/Npp.2008.214  0.787
2008 Hyde TM, Deep-Soboslay A, Iglesias B, Callicott JH, Gold JM, Meyer-Lindenberg A, Honea RA, Bigelow LB, Egan MF, Emsellem EM, Weinberger DR. Enuresis as a premorbid developmental marker of schizophrenia. Brain : a Journal of Neurology. 131: 2489-98. PMID 18669483 DOI: 10.1093/Brain/Awn167  0.421
2008 Skelley SL, Goldberg TE, Egan MF, Weinberger DR, Gold JM. Verbal and visual memory: characterizing the clinical and intermediate phenotype in schizophrenia. Schizophrenia Research. 105: 78-85. PMID 18617370 DOI: 10.1016/J.Schres.2008.05.027  0.536
2008 Ceaser AE, Goldberg TE, Egan MF, McMahon RP, Weinberger DR, Gold JM. Set-shifting ability and schizophrenia: a marker of clinical illness or an intermediate phenotype? Biological Psychiatry. 64: 782-8. PMID 18597738 DOI: 10.1016/J.Biopsych.2008.05.009  0.854
2008 Gold JM, Waltz JA, Prentice KJ, Morris SE, Heerey EA. Reward processing in schizophrenia: a deficit in the representation of value. Schizophrenia Bulletin. 34: 835-47. PMID 18591195 DOI: 10.1093/Schbul/Sbn068  0.718
2008 Keefe RSE, Harvey PD, Goldberg TE, Gold JM, Walker TM, Kennel C, Hawkins K. Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS) Schizophrenia Research. 102: 108-115. PMID 18495435 DOI: 10.1016/J.Schres.2008.03.024  0.529
2008 Luck SJ, Gold JM. The translation of cognitive paradigms for patient research. Schizophrenia Bulletin. 34: 629-44. PMID 18487226 DOI: 10.1093/Schbul/Sbn036  0.429
2008 Dickinson D, Ragland JD, Gold JM, Gur RC. General and specific cognitive deficits in schizophrenia: Goliath defeats David? Biological Psychiatry. 64: 823-7. PMID 18472089 DOI: 10.1016/J.Biopsych.2008.04.005  0.503
2008 Freedman R, Olincy A, Buchanan RW, Harris JG, Gold JM, Johnson L, Allensworth D, Guzman-Bonilla A, Clement B, Ball MP, Kutnick J, Pender V, Martin LF, Stevens KE, Wagner BD, et al. Initial phase 2 trial of a nicotinic agonist in schizophrenia. The American Journal of Psychiatry. 165: 1040-7. PMID 18381905 DOI: 10.1176/Appi.Ajp.2008.07071135  0.45
2008 Heerey EA, Bell-Warren KR, Gold JM. Decision-making impairments in the context of intact reward sensitivity in schizophrenia. Biological Psychiatry. 64: 62-9. PMID 18377874 DOI: 10.1016/J.Biopsych.2008.02.015  0.515
2008 Luck SJ, Gold JM. The construct of attention in schizophrenia. Biological Psychiatry. 64: 34-9. PMID 18374901 DOI: 10.1016/J.Biopsych.2008.02.014  0.53
2008 Dickinson D, Gold JM, Dickerson FB, Medoff D, Dixon LB. Evidence of exacerbated cognitive deficits in schizophrenia patients with comorbid diabetes. Psychosomatics. 49: 123-31. PMID 18354065 DOI: 10.1176/Appi.Psy.49.2.123  0.482
2008 Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, et al. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. The American Journal of Psychiatry. 165: 203-13. PMID 18172019 DOI: 10.1176/Appi.Ajp.2007.07010042  0.463
2008 Kern RS, Nuechterlein KH, Green MF, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Mintz J, Seidman LJ, Stover E, Marder SR. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. The American Journal of Psychiatry. 165: 214-20. PMID 18172018 DOI: 10.1176/Appi.Ajp.2007.07010043  0.384
2008 Green MF, Nuechterlein KH, Kern RS, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Seidman LJ, Stover E, Marder SR. Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. The American Journal of Psychiatry. 165: 221-8. PMID 18172017 DOI: 10.1176/Appi.Ajp.2007.07010089  0.41
2008 Buchanan RW, Conley RR, Dickinson D, Ball MP, Feldman S, Gold JM, McMahon RP. Galantamine for the treatment of cognitive impairments in people with schizophrenia. The American Journal of Psychiatry. 165: 82-9. PMID 17986678 DOI: 10.1176/Appi.Ajp.2007.07050724  0.492
2008 Prentice KJ, Gold JM, Buchanan RW. The Wisconsin Card Sorting impairment in schizophrenia is evident in the first four trials. Schizophrenia Research. 106: 81-7. PMID 17933496 DOI: 10.1016/J.Schres.2007.07.015  0.558
2008 Morris SE, Heerey EA, Gold JM, Holroyd CB. Learning-related changes in brain activity following errors and performance feedback in schizophrenia. Schizophrenia Research. 99: 274-85. PMID 17889510 DOI: 10.1016/J.Schres.2007.08.027  0.51
2008 Dickinson D, Gold JM. Less unique variance than meets the eye: overlap among traditional neuropsychological dimensions in schizophrenia. Schizophrenia Bulletin. 34: 423-34. PMID 17702991 DOI: 10.1093/Schbul/Sbm092  0.5
2008 Longenecker J, Genderson J, Gold JM, Elvevåg B, Weinberger DR. WHERE HAVE ALL THE WOMEN GONE? GENDER IN EXPERIMENTAL AND EPIDEMIOLOGICAL RESEARCH OF SCHIZOPHRENIA Schizophrenia Research. 102: 204. DOI: 10.1016/S0920-9964(08)70617-0  0.429
2008 Prust M, Tan H, Mattay V, Gold J, Weinberger DR, Callicott J. WORKING MEMORY CAPACITY AND INDIVIDUAL RESPONSE DIFFERENCES TO INCREASING COGNITIVE LOAD Schizophrenia Research. 102: 101. DOI: 10.1016/S0920-9964(08)70305-0  0.335
2008 Gold JM. Is cognitive impairment in schizophrenia ready for diagnostic prime time? World Psychiatry. 7: 32-33.  0.428
2007 Robles O, Blaxton T, Adami H, Arango C, Thaker G, Gold J. Nonverbal delayed recognition in the relatives of schizophrenia patients with or without schizophrenia spectrum. Biological Psychiatry. 63: 498-504. PMID 17916332 DOI: 10.1016/J.Biopsych.2007.05.016  0.59
2007 Buchanan RW, Javitt DC, Marder SR, Schooler NR, Gold JM, McMahon RP, Heresco-Levy U, Carpenter WT. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. The American Journal of Psychiatry. 164: 1593-602. PMID 17898352 DOI: 10.1176/Appi.Ajp.2007.06081358  0.463
2007 Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuano G, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Davis CE, et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Archives of General Psychiatry. 64: 633-47. PMID 17548746 DOI: 10.1001/Archpsyc.64.6.633  0.401
2007 Gold JM, Fuller RL, Robinson BM, Braun EL, Luck SJ. Impaired top-down control of visual search in schizophrenia. Schizophrenia Research. 94: 148-55. PMID 17544632 DOI: 10.1016/J.Schres.2007.04.023  0.482
2007 Heerey EA, Gold JM. Patients with schizophrenia demonstrate dissociation between affective experience and motivated behavior. Journal of Abnormal Psychology. 116: 268-78. PMID 17516760 DOI: 10.1037/0021-843X.116.2.268  0.513
2007 Dickinson D, Ramsey ME, Gold JM. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Archives of General Psychiatry. 64: 532-42. PMID 17485605 DOI: 10.1001/Archpsyc.64.5.532  0.527
2007 Waltz JA, Gold JM. Probabilistic reversal learning impairments in schizophrenia: further evidence of orbitofrontal dysfunction. Schizophrenia Research. 93: 296-303. PMID 17482797 DOI: 10.1016/J.Schres.2007.03.010  0.723
2007 Heerey EA, Robinson BM, McMahon RP, Gold JM. Delay discounting in schizophrenia. Cognitive Neuropsychiatry. 12: 213-21. PMID 17453902 DOI: 10.1080/13546800601005900  0.519
2007 Waltz JA, Frank MJ, Robinson BM, Gold JM. Selective reinforcement learning deficits in schizophrenia support predictions from computational models of striatal-cortical dysfunction. Biological Psychiatry. 62: 756-64. PMID 17300757 DOI: 10.1016/J.Biopsych.2006.09.042  0.698
2007 Dickinson D, Bellack AS, Gold JM. Social/communication skills, cognition, and vocational functioning in schizophrenia. Schizophrenia Bulletin. 33: 1213-20. PMID 17164469 DOI: 10.1093/Schbul/Sbl067  0.448
2007 Cohen AS, Saperstein AM, Gold JM, Kirkpatrick B, Carpenter WT, Buchanan RW. Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date. Schizophrenia Bulletin. 33: 1201-12. PMID 17159230 DOI: 10.1093/Schbul/Sbl066  0.533
2006 Avila MT, Robles O, Hong LE, Blaxton TA, Myers CS, Wonodi I, Gold J, Thaker GK. Deficits on the Continuous Performance Test within the schizophrenia spectrum and the mediating effects of family history of schizophrenia. Journal of Abnormal Psychology. 115: 771-8. PMID 17100534 DOI: 10.1037/0021-843X.115.4.771  0.547
2006 Gold JM, Fuller RL, Robinson BM, McMahon RP, Braun EL, Luck SJ. Intact attentional control of working memory encoding in schizophrenia. Journal of Abnormal Psychology. 115: 658-73. PMID 17100524 DOI: 10.1037/0021-843X.115.4.658  0.5
2006 Fuller RL, Luck SJ, Braun EL, Robinson BM, McMahon RP, Gold JM. Impaired control of visual attention in schizophrenia. Journal of Abnormal Psychology. 115: 266-75. PMID 16737391 DOI: 10.1037/0021-843X.115.2.266  0.522
2006 Shepard PD, Holcomb HH, Gold JM. Schizophrenia in translation: the presence of absence: habenular regulation of dopamine neurons and the encoding of negative outcomes. Schizophrenia Bulletin. 32: 417-21. PMID 16717257 DOI: 10.1093/Schbul/Sbj083  0.511
2006 Luck SJ, Fuller RL, Braun EL, Robinson B, Summerfelt A, Gold JM. The speed of visual attention in schizophrenia: electrophysiological and behavioral evidence. Schizophrenia Research. 85: 174-95. PMID 16713184 DOI: 10.1016/J.Schres.2006.03.040  0.532
2006 Saperstein AM, Fuller RL, Avila MT, Adami H, McMahon RP, Thaker GK, Gold JM. Spatial working memory as a cognitive endophenotype of schizophrenia: assessing risk for pathophysiological dysfunction. Schizophrenia Bulletin. 32: 498-506. PMID 16687386 DOI: 10.1093/Schbul/Sbj072  0.554
2006 Keefe RS, Bilder RM, Harvey PD, Davis SM, Palmer BW, Gold JM, Meltzer HY, Green MF, Miller DD, Canive JM, Adler LW, Manschreck TC, Swartz M, Rosenheck R, Perkins DO, et al. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2033-46. PMID 16641947 DOI: 10.1038/Sj.Npp.1301072  0.518
2006 Velligan DI, Kern RS, Gold JM. Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies Schizophrenia Bulletin. 32: 474-485. PMID 16641424 DOI: 10.1093/Schbul/Sbj071  0.505
2006 Dickinson D, Ragland JD, Calkins ME, Gold JM, Gur RC. A comparison of cognitive structure in schizophrenia patients and healthy controls using confirmatory factor analysis. Schizophrenia Research. 85: 20-9. PMID 16616831 DOI: 10.1016/J.Schres.2006.03.003  0.525
2006 Potter D, Summerfelt A, Gold J, Buchanan RW. Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia. Schizophrenia Bulletin. 32: 692-700. PMID 16469942 DOI: 10.1093/Schbul/Sbj050  0.431
2006 Keefe RS, Young CA, Rock SL, Purdon SE, Gold JM, Breier A. One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia. Schizophrenia Research. 81: 1-15. PMID 16202565 DOI: 10.1016/J.Schres.2005.07.038  0.472
2005 Wilk CM, Gold JM, McMahon RP, Humber K, Iannone VN, Buchanan RW. No, it is not possible to be schizophrenic yet neuropsychologically normal Neuropsychology. 19: 778-786. PMID 16351353 DOI: 10.1037/0894-4105.19.6.778  0.567
2005 Fuller RL, Luck SJ, McMahon RP, Gold JM. Working memory consolidation is abnormally slow in schizophrenia. Journal of Abnormal Psychology. 114: 279-90. PMID 15869358 DOI: 10.1037/0021-843X.114.2.279  0.539
2005 Prentice KJ, Gold JM, Carpenter WT. Optimistic bias in the perception of personal risk: patterns in schizophrenia. The American Journal of Psychiatry. 162: 507-12. PMID 15741467 DOI: 10.1176/Appi.Ajp.162.3.507  0.488
2005 Buchanan RW, Ball MP, Weiner E, Kirkpatrick B, Gold JM, McMahon RP, Carpenter WT. Olanzapine treatment of residual positive and negative symptoms. The American Journal of Psychiatry. 162: 124-9. PMID 15625210 DOI: 10.1016/S0920-9964(03)80437-1  0.49
2005 Gold JM. Cognitive deficits as treatment targets in schizophrenia. Schizophrenia Research. 72: 21-8. PMID 15531404 DOI: 10.1016/J.Schres.2004.09.008  0.49
2004 Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophrenia Research. 72: 29-39. PMID 15531405 DOI: 10.1016/J.Schres.2004.09.007  0.509
2004 Gold JM, Poet MS, Wilk CM, Buchanan RW. The family pictures test as a measure of impaired feature binding in schizophrenia. Journal of Clinical and Experimental Neuropsychology. 26: 511-20. PMID 15512938 DOI: 10.1080/13803390490496669  0.488
2004 Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, Fenton WS, Frese F, Goldberg TE, Heaton RK, Keefe RS, Kern RS, Kraemer H, Stover E, Weinberger DR, et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biological Psychiatry. 56: 301-7. PMID 15336511 DOI: 10.1016/J.Biopsych.2004.06.023  0.502
2004 Wilk CM, Gold JM, Humber K, Dickerson F, Fenton WS, Buchanan RW. Brief cognitive assessment in schizophrenia: normative data for the Repeatable Battery for the Assessment of Neuropsychological Status. Schizophrenia Research. 70: 175-86. PMID 15329294 DOI: 10.1016/J.Schres.2003.10.009  0.449
2004 Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophrenia Research. 68: 283-97. PMID 15099610 DOI: 10.1016/J.Schres.2003.09.011  0.529
2004 Dickinson D, Iannone VN, Wilk CM, Gold JM. General and specific cognitive deficits in schizophrenia. Biological Psychiatry. 55: 826-33. PMID 15050864 DOI: 10.1016/J.Biopsych.2003.12.010  0.565
2003 Keefe RS, Mohs RC, Bilder RM, Harvey PD, Green MF, Meltzer HY, Gold JM, Sano M. Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. Schizophrenia Bulletin. 29: 45-55. PMID 12908660 DOI: 10.1093/Oxfordjournals.Schbul.A006990  0.481
2003 Gold JM, Wilk CM, McMahon RP, Buchanan RW, Luck SJ. Working memory for visual features and conjunctions in schizophrenia. Journal of Abnormal Psychology. 112: 61-71. PMID 12653414 DOI: 10.1037/0021-843X.112.1.61  0.524
2003 Buchanan RW, Summerfelt A, Tek C, Gold J. An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia. Schizophrenia Research. 59: 29-33. PMID 12413639 DOI: 10.1016/S0920-9964(01)00387-5  0.549
2003 Humber K, Wilk C, Dickerson F, Buchanan R, Gold J. Neuropsychological screening in schizophrenia: Psychometric properties of the repeatable battery for the assessment of neuropsychological status (RBANS) Schizophrenia Research. 60: 171. DOI: 10.1016/S0920-9964(03)81042-3  0.472
2003 Robles O, Blaxton T, Gold J, Kakoyannis A, Adami H, Thaker G. A comparison of implicit and explicit nonverbal memory in schizophrenic patients and their first-degree relatives Schizophrenia Research. 60: 154. DOI: 10.1016/S0920-9964(03)80987-8  0.346
2003 Gold J, Wilk C, Humber K, Iannone V, Thaker G, McMahon R, Buchanan R. Cognitive markers of illness and disability in schizophrenia Schizophrenia Research. 60: 135-136. DOI: 10.1016/S0920-9964(03)80930-1  0.529
2003 Dickinson D, Iannone V, Wilk C, Gold J. General and specific cognitive deficits in schizophrenia Schizophrenia Research. 60: 131. DOI: 10.1016/S0920-9964(03)80916-7  0.547
2003 Wonodi I, Stine C, Mitchell B, Gold J, Buchanan R, Thaker G. Prefrontal cortical dysfunction and genetic polymorphisms of the COMT gene in subjects with schizophrenia: A genetic study of a schizophrenia endophenotype Schizophrenia Research. 60: 91-92. DOI: 10.1016/S0920-9964(03)80659-X  0.47
2003 Breier A, Keefe RS, Young CA, Purdon SE, Gold JM, Davis KL. A one-year double-blind comparison of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in patients with schizophrenia Schizophrenia Research. 60: 274-275. DOI: 10.1016/S0920-9964(03)80434-6  0.507
2003 Prentice K, Bellack A, Gold J, Carpenter W. Improving decisional capacity for informed consent in schizophrenia Schizophrenia Research. 60: 327-328. DOI: 10.1016/S0920-9964(03)80298-0  0.498
2003 Morris S, Dickinson D, Bellack A, Tenhula W, Gold J. The development of a computer-based cognitive remediation program for schizophrenia Schizophrenia Research. 60: 326. DOI: 10.1016/S0920-9964(03)80293-1  0.482
2003 Weiner E, Buchanan R, Gold J, Ball P, Bennett M. A comparison of bupropion SR and placebo for smoking cessation in schizophrenia Schizophrenia Research. 60: 305-306. DOI: 10.1016/S0920-9964(03)80234-7  0.411
2003 Bellack AS, Thomas-Lohrman S, Gold JM, Gearon JS, Dixon L, Brown CH. Generalized deficits in social skills in some, but not all, patients with schizophrenia Schizophrenia Research. 60: 11. DOI: 10.1016/S0920-9964(03)80030-0  0.492
2002 Gold JM, Thaker GK. Current progress in schizophrenia research: cognitive phenotypes of schizophrenia: attention. The Journal of Nervous and Mental Disease. 190: 638-9. PMID 12357099 DOI: 10.1097/00005053-200209000-00010  0.555
2002 Gold JM, Goldberg RW, McNary SW, Dixon LB, Lehman AF. Cognitive correlates of job tenure among patients with severe mental illness. The American Journal of Psychiatry. 159: 1395-402. PMID 12153834 DOI: 10.1176/Appi.Ajp.159.8.1395  0.438
2002 Dickinson D, Iannone VN, Gold JM. Factor structure of the Wechsler Adult Intelligence Scale-III in schizophrenia. Assessment. 9: 171-80. PMID 12066832 DOI: 10.1177/10791102009002008  0.414
2002 Carpenter WT, Gold JM. Another view of therapy for cognition in schizophrenia. Biological Psychiatry. 51: 969-71. PMID 12062880 DOI: 10.1016/S0006-3223(02)01399-9  0.493
2002 Wilk CM, Gold JM, Bartko JJ, Dickerson F, Fenton WS, Knable M, Randolph C, Buchanan RW. Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia. The American Journal of Psychiatry. 159: 838-44. PMID 11986139 DOI: 10.1176/Appi.Ajp.159.5.838  0.472
2002 Tek C, Gold J, Blaxton T, Wilk C, McMahon RP, Buchanan RW. Visual perceptual and working memory impairments in schizophrenia. Archives of General Psychiatry. 59: 146-53. PMID 11825136 DOI: 10.1001/Archpsyc.59.2.146  0.491
2001 Thaker G, Adami H, Gold J. Functional deterioration in individuals with schizophrenia spectrum personality symptoms. Journal of Personality Disorders. 15: 229-34. PMID 11406994 DOI: 10.1521/Pedi.15.3.229.19207  0.438
2001 Bellack AS, Weinhardt LS, Gold JM, Gearon JS. Generalization of training effects in schizophrenia. Schizophrenia Research. 48: 255-62. PMID 11295378 DOI: 10.1016/S0920-9964(00)00066-9  0.325
2001 Weiner E, Ball MP, Summerfelt A, Gold J, Buchanan RW. Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia. The American Journal of Psychiatry. 158: 635-7. PMID 11282701 DOI: 10.1176/Appi.Ajp.158.4.635  0.435
2001 Goldberg RW, Green-Paden LD, Lehman AF, Gold JM. Correlates of insight in serious mental illness. The Journal of Nervous and Mental Disease. 189: 137-45. PMID 11277349 DOI: 10.1097/00005053-200103000-00001  0.304
2001 Blyler CR, Gold JM, Iannone VN, Buchanan RW. Short form of the WAIS-III for use with patients with schizophrenia. Schizophrenia Research. 46: 209-15. PMID 11120433 DOI: 10.1016/S0920-9964(00)00017-7  0.51
2001 Bellack AS, Buchanan RW, Gold JM. The American Psychiatric Association practice guidelines for schizophrenia: Scientific base and relevance for behavior therapy Behavior Therapy. 32: 283-308. DOI: 10.1016/S0005-7894(01)80006-X  0.422
2000 Gold JM, Rehkemper G, Binks SW, Carpenter CJ, Fleming K, Goldberg TE, Weinberger DR. Learning and forgetting in schizophrenia. Journal of Abnormal Psychology. 109: 534-8. PMID 11016123 DOI: 10.1037//0021-843X.109.3.534  0.398
2000 Weickert TW, Goldberg TE, Gold JM, Bigelow LB, Egan MF, Weinberger DR. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Archives of General Psychiatry. 57: 907-13. PMID 10986554 DOI: 10.1001/Archpsyc.57.9.907  0.584
2000 Gold JM, Bish JA, Iannone VN, Hobart MP, Queern CA, Buchanan RW. Effects of contextual processing on visual conditional associative learning in schizophrenia. Biological Psychiatry. 48: 406-14. PMID 10978724 DOI: 10.1016/S0006-3223(00)00930-6  0.397
2000 Carpenter WT, Gold JM, Lahti AC, Queern CA, Conley RR, Bartko JJ, Kovnick J, Appelbaum PS. Decisional capacity for informed consent in schizophrenia research. Archives of General Psychiatry. 57: 533-8. PMID 10839330 DOI: 10.1001/Archpsyc.57.6.533  0.5
2000 Lenzenweger MF, Gold JM. Auditory working memory and verbal recall memory in schizotypy Schizophrenia Research. 42: 101-110. PMID 10742648 DOI: 10.1016/S0920-9964(99)00121-8  0.424
2000 Gold JM, Rehkemper G, Binks SW, Carpenter CJ, Fleming K, Goldberg TE, Weinberger DR. Learning and forgetting in schizophrenia. Journal of Abnormal Psychology. 109: 534-538. DOI: 10.1037/0021-843X.109.3.534  0.578
1999 Hobart MP, Goldberg R, Bartko JJ, Gold JM. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons. The American Journal of Psychiatry. 156: 1951-7. PMID 10588410 DOI: 10.1176/Ajp.156.12.1951  0.537
1999 Gold JM, Queern C, Iannone VN, Buchanan RW. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity. The American Journal of Psychiatry. 156: 1944-50. PMID 10588409 DOI: 10.1176/Ajp.156.12.1944  0.48
1999 Arango C, Bartko JJ, Gold JM, Buchanan RW. Prediction of neuropsychological performance by neurological signs in schizophrenia. The American Journal of Psychiatry. 156: 1349-57. PMID 10484944 DOI: 10.1176/Ajp.156.9.1349  0.479
1999 Bellack AS, Gold JM, Buchanan RW. Cognitive rehabilitation for schizophrenia: problems, prospects, and strategies. Schizophrenia Bulletin. 25: 257-74. PMID 10416730 DOI: 10.1093/Oxfordjournals.Schbul.A033377  0.494
1999 Gourovitch ML, Torrey EF, Gold JM, Randolph C, Weinberger DR, Goldberg TE. Neuropsychological performance of monozygotic twins discordant for bipolar disorder Biological Psychiatry. 45: 639-646. PMID 10088052 DOI: 10.1016/S0006-3223(98)00148-6  0.467
1999 Gold J. Schizophrenia From a Neurocognitive Perspective: Probing the Impenetrable Darkness. The Journal of Nervous & Mental Disease. 187: 192-193. DOI: 10.1097/00005053-199903000-00011  0.524
1998 Gold J, David A, Stevens JR, Stevens CM, Wyatt RJ, Russell AJ, Murray RM. Schizophrenia and intellectual decline [14] (multiple letters) American Journal of Psychiatry. 155: 1633-1637. PMID 9812144 DOI: 10.1176/Ajp.155.11.1626M  0.543
1998 Tamminga CA, Buchanan RW, Gold JM. The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. International Clinical Psychopharmacology. S21-6. PMID 9690966 DOI: 10.1097/00004850-199803003-00004  0.487
1998 Gold J, Russell AJ, Murray RM. Intellectual decline in schizophrenic patients [6] (multiple letters) American Journal of Psychiatry. 155: 995-996. PMID 9659878 DOI: 10.1176/Ajp.155.7.995B  0.33
1998 Van Horn JD, Gold JM, Esposito G, Ostrem JL, Mattay V, Weinberger DR, Berman KF. Changing patterns of brain activation during maze learning. Brain Research. 793: 29-38. PMID 9630492 DOI: 10.1016/S0006-8993(98)00051-1  0.358
1998 Goldberg TE, Berman KF, Fleming K, Ostrem J, Van Horn JD, Esposito G, Mattay VS, Gold JM, Weinberger DR. Uncoupling cognitive workload and prefrontal cortical physiology: a PET rCBF study. Neuroimage. 7: 296-303. PMID 9626670 DOI: 10.1006/Nimg.1998.0338  0.389
1998 Binks SW, Gold JM. Differential Cognitive Deficits in the Neuropsychology of Schizophrenia The Clinical Neuropsychologist. 12: 8-20. DOI: 10.1076/Clin.12.1.8.1730  0.457
1997 Goldberg TE, Gold JM, Coppola R, Weinberger DR. Unnatural practices, unspeakable actions: A study of delayed auditory feedback in schizophrenia American Journal of Psychiatry. 154: 858-860. PMID 9167517 DOI: 10.1176/Ajp.154.6.858  0.5
1997 Gold JM, Carpenter C, Randolph C, Goldberg TE, Weinberger DR. Auditory working memory and Wisconsin card sorting test performance in schizophrenia Archives of General Psychiatry. 54: 159-165. PMID 9040284 DOI: 10.1001/Archpsyc.1997.01830140071013  0.577
1997 Fleming K, Goldberg TE, Binks S, Randolph C, Gold JM, Weinberger DR. Visuospatial working memory in patients with schizophrenia Biological Psychiatry. 41: 43-49. PMID 8988794 DOI: 10.1016/S0006-3223(96)00263-6  0.529
1997 Buchanan RW, Gold JM. Negative symptoms: diagnosis, treatment and prognosis. International Clinical Psychopharmacology. 3-11. PMID 8803654 DOI: 10.1097/00004850-199605002-00002  0.353
1997 Gold JM, Bryant NL, Vladar K, Buchanan RW. Successful vocational functioning in schizophrenia Schizophrenia Research. 24: 222. DOI: 10.1016/S0920-9964(97)82638-2  0.526
1997 Bustillo J, Gold J, Thaker G, Buchanan R. Inhibition of return in schizophrenia Schizophrenia Research. 24: 99. DOI: 10.1016/S0920-9964(97)82269-4  0.514
1996 Goldberg TE, Berman KF, Randolph C, Gold JM, Weinberger DR. Isolating the mnemonic component in spatial delayed response: a controlled PET 15O-labeled water regional cerebral blood flow study in normal humans. Neuroimage. 3: 69-78. PMID 9345477 DOI: 10.1006/Nimg.1996.0008  0.323
1996 Gold JM. PET validation of a novel prefrontal task: Delayed response alternation Neuropsychology. 10: 3-10. DOI: 10.1037/0894-4105.10.1.3  0.37
1995 Goldberg TE, Torrey EF, Gold JM, Bigelow LB, Ragland RD, Taylor E, Weinberger DR. Genetic risk of neuropsychological impairment in schizophrenia: a study of monozygotic twins discordant and concordant for the disorder. Schizophrenia Research. 17: 77-84. PMID 8541253 DOI: 10.1016/0920-9964(95)00032-H  0.54
1995 Gold JM, Blaxton TA, Hermann BP, Randolph C, Fedio P, Goldberg TE, Theodore WH, Weinberger DR. Memory and intelligence in lateralized temporal lobe epilepsy and schizophrenia. Schizophrenia Research. 17: 59-65. PMID 8541251 DOI: 10.1016/0920-9964(95)00030-P  0.467
1995 Berman KF, Ostrem JL, Randolph C, Gold J, Goldberg TE, Coppola R, Carson RE, Herscovitch P, Weinberger DR. Physiological activation of a cortical network during performance of the Wisconsin Card Sorting Test: a positron emission tomography study. Neuropsychologia. 33: 1027-46. PMID 8524452 DOI: 10.1016/0028-3932(95)00035-2  0.339
1995 Goldberg TE, Gold JM, Torrey EF, Weinberger DR. Lack of sex differences in the neuropsychological performance of patients with schizophrenia American Journal of Psychiatry. 152: 883-888. PMID 7755118 DOI: 10.1176/Ajp.152.6.883  0.445
1995 Fleming K, Goldberg TE, Gold JM, Weinberger DR. Verbal working memory dysfunction in schizophrenia: use of a Brown-Peterson paradigm Psychiatry Research. 56: 155-161. PMID 7667440 DOI: 10.1016/0165-1781(95)02589-3  0.532
1995 Gold JM, Weinberger DR. Cognitive deficits and the neurobiology of schizophrenia. Current Opinion in Neurobiology. 5: 225-30. PMID 7620311 DOI: 10.1016/0959-4388(95)80030-1  0.528
1995 Goldberg TE, Gold JM, Fuller Torrey E, Weinberger DR. Sex differences and neurocognition in schizophrenia Schizophrenia Research. 15: 118. DOI: 10.1016/0920-9964(95)95363-E  0.518
1994 Gold JM, Hermann BP, Randolph C, Wyler AR, Goldberg TE, Weinberger DR. Schizophrenia and Temporal Lobe Epilepsy: A Neuropsychological Analysis Archives of General Psychiatry. 51: 265-272. PMID 8161286 DOI: 10.1001/Archpsyc.1994.03950040009001  0.544
1994 Goldberg T, Gold J, Coppola R, Weinberger D. The effects of delayed auditory feedback on speech in schizophrenia Biological Psychiatry. 35: 659. DOI: 10.1016/0006-3223(94)90817-6  0.31
1994 Gold J, Blaxton T, Hermann B, Goldberg T, Wyler A, Theodore W, Weinberger D. Neuropsychological differences between schizophrenia and temporal lobe epilepsy Biological Psychiatry. 35: 635. DOI: 10.1016/0006-3223(94)90730-7  0.473
1993 Goldberg TE, Torrey EF, Gold JM, Ragland JD, Bigelow LB, Weinberger DR. Learning and memory in monozygotic twins discordant for schizophrenia. Psychological Medicine. 23: 71-85. PMID 8475218 DOI: 10.1017/S0033291700038861  0.477
1993 Torrey EF, Ragland JD, Gold JM, Goldberg TE, Bowler AE, Bigelow LB, Gottesman II. Handedness in twins with schizophrenia: was Boklage correct? Schizophrenia Research. 9: 83-5. PMID 8461274 DOI: 10.1016/0920-9964(93)90014-A  0.48
1993 Goldberg TE, Greenberg RD, Griffin SJ, Gold JM, Kleinman JE, Pickar D, Schulz SC, Weinberger DR. The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 162: 43-8. PMID 8425138 DOI: 10.1192/Bjp.162.1.43  0.546
1993 Goldberg TE, Gold JM, Greenberg R, Griffin S, Schulz SC, Pickar D, Kleinman JE, Weinberger DR. Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery. The American Journal of Psychiatry. 150: 1355-62. PMID 8352346 DOI: 10.1176/ajp.150.9.1355  0.417
1993 Gold JM, Harvey PD. Cognitive deficits in schizophrenia. The Psychiatric Clinics of North America. 16: 295-312. PMID 8332566  0.492
1993 Randolph C, Hyde TM, Gold JM, Goldberg TE, Weinberger DR. Tourette's Syndrome in Monozygotic Twins: Relationship of Tic Severity to Neuropsychological Function Archives of Neurology. 50: 725-728. PMID 8323476 DOI: 10.1001/Archneur.1993.00540070045013  0.31
1993 Randolph C, Gold JM, Carpenter CJ, Goldberg TE, Weinberger DR. Implicit memory in patients with schizophrenia and normal controls: effects of task demands on susceptibility to priming. Journal of Clinical and Experimental Neuropsychology. 15: 853-66. PMID 8120123 DOI: 10.1080/01688639308402603  0.459
1993 Gold JM, Harvey PD. Cognitive Deficits in Schizophrenia Psychiatric Clinics of North America. 16: 295-312. DOI: 10.1016/S0193-953X(18)30175-8  0.543
1993 Goldberg T, Nowlin B, Gold J, Weinberger D. Remote memory in schizophrenia Schizophrenia Research. 9: 175. DOI: 10.1016/0920-9964(93)90340-O  0.508
1993 Goldberg T, Weinberger D, Gold J, Greenberg R, Griffin S, Schulz S, Pickar D, Kleinman J. Neuropsychological specificity and schizophrenia: A comparison with affective groups Schizophrenia Research. 9: 175. DOI: 10.1016/0920-9964(93)90339-K  0.528
1993 Gold J, Blaxton T, Hermann B, Randolph C, Fedio P, Goldberg T, Theodore W, Weinberger D. Memory and IQ in schizophrenia and temporal lobe epilepsy Schizophrenia Research. 9: 174. DOI: 10.1016/0920-9964(93)90338-J  0.467
1992 Ragland JD, Goldberg TE, Wexler BE, Gold JM, Torrey EF, Weinberger DR. Dichotic listening in monozygotic twins discordant and concordant for schizophrenia. Schizophrenia Research. 7: 177-83. PMID 1515379 DOI: 10.1016/0920-9964(92)90048-A  0.451
1992 Gold JM, Randolph C, Carpenter CJ, Goldberg TE, Weinberger DR. Forms of memory failure in schizophrenia. Journal of Abnormal Psychology. 101: 487-94. PMID 1500605 DOI: 10.1037/0021-843X.101.3.487  0.506
1992 Randolph C, Gold JM, Carpenter CJ, Goldberg TE, Weinberger DR. Release from proactive interference: determinants of performance and neuropsychological correlates. Journal of Clinical and Experimental Neuropsychology. 14: 785-800. PMID 1474146 DOI: 10.1080/01688639208402863  0.397
1992 Gold JM, Randolph C, Coppola R, Carpenter CJ, Goldberg TE, Weinberger DR. Visual orienting in schizophrenia. Schizophrenia Research. 7: 203-9. PMID 1390400 DOI: 10.1016/0920-9964(92)90013-U  0.446
1992 Gold JM, Randolph C, Carpenter CJ, Goldberg TE, Weinberger DR. The performance of patients with schizophrenia on the wechsler memory scale-revised Clinical Neuropsychologist. 6: 367-373. DOI: 10.1080/13854049208401864  0.467
1992 Gold JM, Randolph C, Carpenter CJ, Goldberg TE, Weinberger DR. Forms of memory failure in schizophrenia. Journal of Abnormal Psychology. 101: 487-494. DOI: 10.1037/0021-843X.101.3.487  0.38
1991 Gold JM, Egan MF, Kirch DG, Goldberg TE, Daniel DG, Bigelow LB, Wyatt RJ. Tardive dyskinesia: neuropsychological, computerized tomographic, and psychiatric symptom findings. Biological Psychiatry. 30: 587-99. PMID 1681948 DOI: 10.1016/0006-3223(91)90028-K  0.425
1991 Stevens JR, Gold JM. What is schizophrenia? Behavioral and Brain Sciences. 14: 50-51. DOI: 10.1017/S0140525X00065377  0.532
1991 Berman K, Randolph C, Gold J, Abi-Dargham A, Jones D, Golderg T, Carson R, Herscovitch P, Weinberger D. PET studies of frontal lobe function during cognition Schizophrenia Research. 4: 399. DOI: 10.1016/0920-9964(91)90344-Q  0.32
1991 Randolph C, Gold J, Goldberg T, Weinberger D. Implicit memory function in schizophrenia Schizophrenia Research. 4: 391. DOI: 10.1016/0920-9964(91)90333-M  0.509
1991 Greenberg R, Goldberg T, Griffin S, Gold J, Kleinman J, Pickar D, Weinberger D. Effects of clozapine on cognition in patients with schizophrenia Schizophrenia Research. 4: 385. DOI: 10.1016/0920-9964(91)90322-I  0.535
1991 Goldberg T, Torrey E, Gold J, Ragland J, Bigelow L, Weinberger B. Memory function in monozygotic twins discordant for schizophrenia Schizophrenia Research. 4: 384. DOI: 10.1016/0920-9964(91)90320-Q  0.51
1991 Gold J, Randolph C, Carpenter C, Goldberg T, Weinberger D. Forms of memory failure in schizophrenia Schizophrenia Research. 4: 383-384. DOI: 10.1016/0920-9964(91)90319-M  0.482
1991 Clardy J, Daniel D, Breslin N, Gold J, Kleinman J, Winberger D. A trial of L-dopa and molindone in schizophrenia Schizophrenia Research. 4: 315-316. DOI: 10.1016/0920-9964(91)90207-8  0.453
1990 Coppola R, Gold J. What is left of attention in schizophrenia? Archives of General Psychiatry. 47: 393-5. PMID 2322090 DOI: 10.1001/Archpsyc.1990.01810160093014  0.474
1990 Goldberg TE, Ragland JD, Torrey EF, Gold JM, Bigelow LB, Weinberger DR. Neuropsychological assessment of monozygotic twins discordant for schizophrenia. Archives of General Psychiatry. 47: 1066-72. PMID 2241508 DOI: 10.1001/Archpsyc.1990.01810230082013  0.496
1990 Gold JM, Hurt SW. The effects of haloperidol on thought disorder and IQ in schizophrenia. Journal of Personality Assessment. 54: 390-400. PMID 2179521 DOI: 10.1080/00223891.1990.9674002  0.457
1989 Gold J, Egan M, Goldberg T, Kirch D. Cognitive impairment and tardive dyskinesia Schizophrenia Research. 2: 236. DOI: 10.1016/0920-9964(89)90272-7  0.334
1988 Medalia A, Gold J, Merriam A. The effects of neuroleptics on neuropsychological test results of schizophrenics Archives of Clinical Neuropsychology. 3: 249-271. DOI: 10.1093/Arclin/3.3.249  0.453
Show low-probability matches.